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ABSTRACT 
Previous work in the Simpkins group includes the Michael addition reactions of 
triketopiperazines (TKPs). These were performed asymmetrically using modified cinchona 
alkaloid catalysts. The aim of this project was to expand the range of substrates that could be 
used in similar organocatalytic reactions. 
Cyclic substrates such as hydantoins and the drug thalidomide did not show any reactivity 
under the Michael addition conditions. Acyclic substrates were also tested and some limited 
success was achieved with an α-phenyl amide substrate. However, a strongly basic guanidine 
catalyst was required, so investigations were therefore carried out into developing chiral 
guanidine catalysts. 
In the course of the project a new method for the arylation of TKP A was developed which 
used diphenyliodonium triflate (DPIT) as the electrophile. Phenyl-TKP B was subsequently 
used in asymmetric Michael additions. A range of catalysts were screened, with modified-
quinine catalyst D performing the best. 
The PMB-protected TKP E was also synthesised and this gave even better yields and 
selectivities when a range of unsaturated ketones were used. 
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In summary, a large number of substrates have been tested and a method for arylating TKPs 
has been developed. Furthermore, some excellent yields and selectivities have been achieved 
for organocatalytic Michael additions. 
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ABBREVIATIONS 
µW microwave IPA isopropyl alcohol 
Ac acetyl iPr isopropyl   
Bn benzyl LDA lithium diisopropylamide 
Boc tert-butyloxycarbonyl LHMDS lithium bis(trimethylsilyl)amide 
Bzt benzotriazole LUMO lowest unoccupied molecular orbital 
CAN ceric ammonium nitrate m.p. melting point 
cf. compare mCPBA meta-chloroperbenzoic acid 
COSY correlation spectroscopy min minute(s) 
Cy cyclohexyl MVK methyl vinyl ketone 
DCC dicyclohexyl carbodiimide NMR nuclear magnetic resonance 
DDQ 
2,3-dichloro-5,6-dicyano-p-
benzoquinone 
NOE nuclear Overhauser effect 
DEAD diethyl azodicarboxylate NR no reaction 
DIAD diisopropyl azodicarboxylate PMB p-methoxybenzyl 
DIPEA diisopropylethylamine PMP p-methoxyphenyl 
DKP diketopiperazine ppm parts per million 
DMAP 4-(dimethylamino)pyridine PTSA p-toluenesulfonic acid 
DMF dimethylformamide Py pyridine 
DMSO dimethyl sulfoxide quant quantitative yield 
DPIT diphenyliodonium triflate rt room temperature 
DPPA diphenylphosphoryl azide SM starting material 
dr diastereomeric ratio tBu tert-butyl 
ee enatiomeric excess TFA trifluoroacetic acid 
equiv equivalents TFAA trifluoroacetic anhydride 
er enantiomeric ratio TfO trifluoromethanesulfonate 
h hour(s) THF tetrahydrofuran 
HMBC 
heteronuclear multiple bond 
correlation 
TKP triketopiperazine 
HPLC 
high performance liquid 
chromatography 
tlc thin later chromatography 
HRMS high resolution mass spectrometry TMG 1,1,3,3-tetramethylguanidine 
HSQC 
heteronuclear single quantum 
correlation 
TMS trimethylsilyl 
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1. INTRODUCTION 
1.1. Organocatalysis 
The field of organocatalysis has expanded rapidly since the beginning of the 21st century. The 
catalysis of reactions with small organic molecules which contain no inorganic element is 
appealing for many reasons; asymmetric organocatalysts can be made from chiral-pool 
molecules and no expensive or toxic metals are required. 
Early work in this area focused on the use of amines to give enamine or iminium intermediates 
which were then used in reactions such as the aldol reaction. The Hajos–Parrish–Eder–Sauer–
Wiechert reaction uses proline as a readily available asymmetric organocatalyst and has been 
used in the synthesis of steroid intermediates.1,2 List and co-workers suggest that the reaction 
proceeds via an enamine intermediate with a Zimmerman−Traxler type transition state 1 
(Scheme 1).3 
Scheme 1 - Hajos–Parrish–Eder–Sauer–Wiechert reaction 
An early example of iminium organocatalysis was published by MacMillan and co-workers in 
2000. They disclosed the first Diels−Alder reaction using enantioselective iminium catalysis 
(Scheme 2).4 The MacMillan family of organocatalysts used for this purpose have an 
imidazolidinone core and are thought to function by lowering the LUMO of the dienophile for 
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the cycloaddition. The bulky benzyl group then provides the facial selectivity for the diene’s 
approach. 
Scheme 2 - MacMillan’s asymmetric Diels−Alder reaction 
These are both examples of Lewis base organocatalysis which has dominated the field to date. 
The three other classes of organocatalysis are: Lewis acid, Brønsted base and Brønsted acid.5 
The Brønsted acid and base forms of catalysis do not involve covalent bond formation with 
the substrate and typically work with much lower catalyst loadings (cf. up to 30 mol% for 
proline catalysis). 
1.2. Cinchona organocatalysis 
Examples of chiral Brønsted bases include the cinchona alkaloids which are isolated from the 
bark of cinchona trees found in the tropical forests of South America. Quinine 2 (Figure 1) is 
one of these alkaloids and it has found numerous medicinal applications, not least for treating 
malaria. It was isolated by Pelletier and Caventou in 18206 and the other main alkaloids 
isolated from the bark were quinidine 3, cinchonine and cinchonidine (Figure 1). 
Figure 1 - cinchona alkaloids 
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The quinoline unit, secondary alcohol and basic quinuclidine included in all of these alkaloids 
make them promising for use as Brønsted basic or bifunctional catalysts. Quinine 2 and 
quinidine 3 (likewise with cinchonidine and cinchonine) are pseudo-enantiomers and 
therefore allow for the possibility of generating enantiomeric products from the 
organocatalytic reaction. These properties have been extensively exploited and many 
modified catalysts have been used to great effect for a range of asymmetric reactions.7 
In 1984, Dolling and co-workers published the first sub-stoichiometric catalytic 
enantioselective alkylation using a phase transfer catalyst. Their optimal catalyst was N-(p-
(trifluoromethyl)benzyl)cinchoninium chloride 5 (Scheme 3) and they achieved 92% ee for the 
methylation of 6,7-dichloro-5-methoxy-2-phenyl-1-indanone 4.8 
Scheme 3 – Dolling and co-workers asymmetric alkylation 
One well explored area of cinchona catalysis is the alkylation of glycine imino esters, such as 
6 (scheme 4), under phase-transfer conditions to give natural and unnatural chiral α-amino 
acids. The free amine of the amino acid is converted to the imine by reacting with 
benzophenone imine and this dramatically lowers the pKa of the substrate. The cinchona-
derived ammonium species 8 is able to solubilise some hydroxide in the organic phase 
allowing for the deprotonation of the glycine equivalent. The resultant ion pair then 
undergoes a conjugate addition with the Michael acceptor with the chiral ammonium 
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counterion providing the enantioinduction. Corey and co-workers published early examples 
of this in 1998 and they achieved enantiomeric excesses of 95% and above (Scheme 4).9 
Scheme 4 - Corey’s asymmetric Michael additions 
In 2012 Barbas and co-workers reported the organocatalytic asymmetric Michael addition of 
pyrazoleamides 9 (Scheme 5). The aromatic group was predicted to give an amide with a 
relatively low pKa which would therefore make it amenable to deprotonation by cinchona 
derived catalysts. The best diastereoselectivity and enantioselectivity was achieved with urea 
groups at the C-9 carbon of the catalyst 10. These bi-functional catalysts are thought to 
operate by the quinuclidine moiety acting as a Brønsted base and the urea unit acting as a 
hydrogen bond donor to activate the resulting enolate and pyrazole. The protonated 
quinuclidine is then thought to activate the nitro olefin. Excellent selectivities were achieved 
with a range of nitro olefins but no other Michael additions were reported. The substrate 
scope was limited to aromatic pyrazoleamides but a range of different aromatic substituents 
were used, and those with electron withdrawing groups gave the best yields and 
stereoselectivity.10 
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Scheme 5 - Barbas’ Michael additions with pyrazoleamides 
1.3. Existing group methodology 
Previous work done by the Simpkins group has included studies on the reactions of 
diketopiperazines (DKPs) and the synthesis of DKP-containing natural products such as the 
stephacidins.11–16 More recently, it was decided to investigate their use as potential substrates 
for cinchona-catalysed Michael additions. It is known that transforming an amide into an imide 
dramatically reduces the pKa of the α-proton (vide infra) so the DKP structure was modified to 
incorporate an additional carbonyl group giving a triketopiperazine (TKP) 12b (Table 1).  
These TKPs have proved to be very effective systems for Michael addition reactions with a 
wide range of Michael acceptors and with high enantioselectivity (Table 1).17 The reaction has 
been proposed to proceed by deprotonation of the TKP by the quinuclidine of the catalyst 13 
and a developing hydrogen bond between the quinoline hydroxyl and the Michael acceptor. 
The resultant complex 14 allows for reaction on only one face of the TKP and this explains the 
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high levels of selectivity achieved. The products from the additionally activated substrates 
with an external ester group have a quaternary stereogenic centre 15a so do not suffer any 
loss of ee under acidic or basic conditions, where as it is suspected that products 15b do suffer 
erosion of their ee due to epimerisation occurring. 
entry TKP R yield (%) ee (%)a 
1 12a Me 99 98 
2 12a H 99 99b 
3 12a p-C6H4Br 98 98 
4 12b Me 80 87 
5 12b H 74 37b 
6 12b p-C6H4Br 97 58 
a determined by HPLC analysis 
b HPLC performed on an acetal derivative 
Table 1 - TKP Michael additions 
Whilst interesting in themselves, TKPs should also be able to be manipulated into useful chiral 
building blocks such as DKPs, piperazines and unnatural amino acids. Preliminary work has 
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shown that the C-3 carbonyl can be selectively reduced due to its enhanced electrophilicity. 
This could then be further reduced to DKP 18 in good yield (Scheme 6).17  
Scheme 6 - further transformations of TKPs 
Alternatively, when acrolein is used as the Michael acceptor, the resultant alcohol 20 after 
reduction with NaBH4 can undergo an N-acyliminium cyclisation under Lewis acidic conditions 
to give bicyclic product 21 (Scheme 6).17  
1.4. Synthesis of TKPs 
The synthesis of DKPs is relatively straightforward as they are the cyclic dimers of amino acids. 
TKPs have presented more of challenge, although several techniques have been developed 
especially as part of the synthesis of TKP containing natural products. 
The most common method has been to couple amino amides and an oxalyl equivalent. Oxalyl 
chloride is usually too reactive for this reaction but diethyl oxalate has been used. In 1953, 
Safir and co-workers reported heating aminoamides such as 22 (Scheme 7) with diethyl 
oxalate under basic conditions. This generated the sodium salt of the TKP which was quenched 
with an aqueous work up to give the desired TKP 23.18 
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Scheme 7 - Safir’s TKP synthesis 
Overman and Shin used a stepwise process in their 2007 synthesis of (+)-gliocladin C 26 
(Scheme 8). Pyrolidine 24 reacted with ethyl chlorooxoacetate to give oxalyl half-ester half-
amide 25. Cyclisations with amine bases or sodium hydride were unsuccessful leading to 
decomposition of the starting material; however heating with HMDS at 140 °C in a sealed tube 
did afford the product in good yield. Elimination of the methoxy group occurred 
simultaneously to give the natural product 26.19 
Scheme 8 - total synthesis of (+)-gliocladin C 
In 2003, Makino and co-workers reported making a large number of TKPs using a solid support. 
A range of amino acids were coupled to solid supported anilines. The oxalyl equivalent they 
used was oxalyl diimidazole and the cyclisation was observed to occur at 25 °C when left 
overnight (Scheme 9). The solid support was then cleaved with TFA. For the phenylaniline 
derivative (R=Bn) the TKP was synthesised in high yield (86%) and high purity (89%).20 Oxalyl 
diimidazole was additionally used by Overman and co-workers in an improved synthesis of (+)-
gliocladin C 26.21 
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Scheme 9 - Makino’s TKP synthesis 
The relative high cost of oxalyl diimidazole led to the development of an alternative coupling 
partner within the Simpkins group. Oxalyl benzotriazole was easily synthesised from oxalyl 
chloride and was successfully used as an alternative (Scheme 10). However, microwave 
conditions were required due to its reduced reactivity.17  
Scheme 10 - Simpkins’ TKP synthesis 
A different route to the TKP motif is to oxidise the corresponding DKP. This can be achieved 
through treating methylene DKPs with singlet oxygen as reported by Machin and Sammes in 
1976.22 Methylene Blue was used as a sensitiser and the reaction was thought to proceed 
through dioxetane intermediate 28 (Scheme 11).  
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Scheme 11 - Machin and Sammes’ oxidative TKP synthesis 
If no methylene unit is in place then it is possible to oxygenate the lithium enolate of the DKP 
as reported by Davies and co-workers in 2002.23 They suggest that the mechanism proceeds 
through the peroxide anion 30 (Scheme 12) with the addition of acetic anhydride giving the 
three observed products. The diastereotopic alcohols 32 and 33 could be oxidised in high yield 
to the TKP with the use of IBX. 
Scheme 12 - Davies’ oxidative TKP synthesis 
In summary, there are a number of ways of accessing the TKP motif with yields and strategies 
depending on the exact nature of the precursor. The predominant method used within the 
Simpkins group to date has been coupling with oxalyl benzotriazole but there is room for 
improvement as the yields have been low to moderate. 
1.5. Project aims 
Having seen the potential for asymmetric organocatalytic Michael additions on amide-like 
systems (Scheme 5 and Table 1), this project began with asking whether other similar systems, 
including acyclic ones could show similar reactivity (Scheme 13).  
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Scheme 13 - target Michael addition 
Given the comparatively low pKas of quinine 2 and quinidine 3 at 7.73 and 7.95 respectively, 
the challenge of making an organic substrate acidic enough to be deprotonated by them was 
rather daunting.24 Calculations on the pKa of TKP 12b are ongoing but we predict that they will 
be somewhat similar to that of a 1,3-dicarbonyl. 
Clearly this project required the use of some electronic effects to help reduce the pKa of an 
amide from its normal value of about 35. Easton and co-workers have done computational 
and experimental work on the effect of electron-withdrawing groups on the proximal and 
distal protons of DKPs 34.25,26 
 
 
Table 2 - Easton’s DKP pKa values 
Table 2 shows the calculated values and it is clear that there is a significant effect on the acidity 
of the distal proton when electron-withdrawing groups are used. Converting an amide to an 
imide therefore gives a pKa drop of over six ‘units’ and is one promising tool for getting in the 
right region for cinchona catalysis.  
Bordwell devoted a large part of his career at Northwestern University to measuring the 
acidities of carbon acids. They used a range of indicators in DMSO to determine the pKa values 
of around 2000 acids.27 This wealth of data proved very useful as we began looking for groups 
which could lower the pKa of our substrates. The most relevant values are summarised in Table 
3.  
R pKa (Hprox) pKa (Hdist) 
H 24.0 24.0 
COCH3 24.1 17.7 
SO2CH3 22.8 16.8 
COCF3 23.7 15.3 
SO2CF3 21.3 13.9 
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R pKa R R’ pKa 
H 24.728 H Et 35.028 
Ph 17.729 Ph Me 26.630 
NMe2 23.631 NMe3+ Br- Et 24.928 
NMe3+ Br- 14.628    
Py+ Br- 10.728    
Table 3 - Bordwell’s ketone and amide pKa values 
A phenyl group at the α position enhances the acidity by about seven or eight pKa ‘units’ 
relative to no substituent at the α position. An amine group gives only a modest reduction in 
pKa, whereas, an ammonium ion gives a reduction of about ten ‘units’. Pyridinium salts give 
an even greater drop of about 14 ‘units’. 
Richard and co-workers have developed an alternative method for determining the pKa of 
carbon acids which uses 1H NMR spectroscopy.32 Equilibrium and rate constants for 
deuteration in D2O allowed for determination of the pKa values. Whilst they managed to 
determine accurate values, both this technique and Bordwell’s indicator method were initially 
considered beyond the scope of this project. However, it was noted that for a series of 
compounds, the chemical shift could be correlated with the acidity. For instance if a functional 
group was modified and the acidic proton chemical shift increases, then this strongly suggests 
that the compound has become more acidic. Whilst not quantitative or accurate this simple 
observation would allow for estimation of acidity through comparing chemical shift values. 
Further to the functional groups already discussed, work had previously been done in the 
Simpkins group on forming amino-borane complexes. Initially, the focus of this work was using 
the borane group to regioselectively metalate benzylamine-type systems with lithium 
bases.33,34 In the absence of borane there is exclusive ortho metalation of the aromatic ring; 
however, activation with a borane group 35 activates with α position to give regioselective α-
metalation (Scheme 14).  
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Scheme 14 - Simpkin’s metallation of benzylamines with and without borane 
This work has been further extended to the diastereoselective and enantioselective alkylation 
of isoindoline-borane complexes.35,36 It was reasoned that the borane group enhances the C-
H acidity by withdrawing electron density away from the nitrogen. To the best of our 
knowledge, no work to date has been done to quantify the effect of boranes on amine pKa 
values. There was potential for using amino boranes as a temporary group to lower the pKa of 
our substrates. 
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2. RESULTS AND DISCUSSION 
2.1. α-Amino amide substrates 
This investigation began by considering the combined effects of converting an amide to an 
imide as well as having an ammonium group in the α-position. It was hoped that these 
combined effects would give us substrates acidic enough to undergo cinchona-catalysed 
Michael additions. Chloroacetamide 38 (Scheme 15) was chosen as the starting material with 
due caution taken due to its toxic and sensitising properties. It was hoped that the chloride 
could be substituted by a nitrogen-containing species which could then be transformed to the 
quaternary ammonium salt.  
Treating chloroacetamide with sodium azide in water cleanly gave the azido amide 39 (Scheme 
15). Staudinger reduction to amine 40 proceeded cleanly by tlc but it proved very difficult to 
separate the product from triphenylphosphine oxide. Hydrogenation with a palladium on 
carbon catalyst also proved ineffective for yielding amino amide 40 possibly due to the very 
high polarity of the product. In order to try to decrease the polarity, Boc protection was first 
performed on the azido amide. Substrate 41 was then tested in a Michael addition reaction 
with tetramethylguanidine (TMG) used as the base. Unfortunately the crude NMR spectrum 
showed remaining starting material, decomposition products, and none of desired product. 
Reduction of Boc-protected azido amide 41 was not attempted due to success in parallel 
routes to amino amides. 
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Scheme 15 - progress towards amino amide substrates 
Attempts to form the ammonium directly from chloroacetamide 38 involved heating under 
reflux with tribenzylamine and catalytic DMAP in ethanol. It was hoped that using benzyl 
groups would also allow for their subsequent removal to give a neutral species following the 
Michael addition. However, no reaction was observed so chloroacetamide 35 was instead 
treated with a secondary amine (Scheme 16) with an in situ Finkelstein reaction occurring. 
Amino amide 43 was then Boc protected to give imide 44. Gentle conditions using DMAP in 
THF surprisingly gave a mixture of bis-Boc amide 45 and the starting material regardless of 
how much Boc2O was used in the reaction. Bis-Boc amide 45 was used in a Michael reaction 
with TMG catalyst and methyl vinyl ketone (MVK) but no product was formed. Attempts to 
remove one of the Boc groups by treating with mild acid and base were also unsuccessful and 
returned only the starting material. 
The use of sodium hydride did allow for singly Boc-protected amide 44 to be isolated but only 
in a modest 52% yield (Scheme 16). Further reflection on the mechanism of reaction with the 
cinchona catalysts revealed that generating an ammonium might not be very favourable. It 
was thought that the chiral environment is sustained after the deprotonation of the substrate 
due to the ion pair that is generated between the catalyst and substrate. A cationic substrate 
would become an ylide after deprotonation and thus the ‘ion pair’ is unlikely to be tight, if 
they bind together at all. Attention therefore turned to the use of boranes to activate the 
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amine (Section 1.5) and 46 was formed in good yield with the CH2 group having a chemical 
shift of 3.9 ppm (cf. 4.2 ppm for TKP 12b). To our surprise, the subsequent Michael addition 
gave Michael adduct 47 and none of the desired product 48.  
Scheme 16 - synthesis and use of amino-borane substrates 
To prevent this Michael addition happening, amino borane 46 was treated with sodium 
hydride, followed by methyl iodide. However, no methylation of the imide was observed, with 
only starting material recovered from the reaction (Scheme 17). Similar attempts to methylate 
precursor amino amide 44 were also unsuccessful. It looked like this route could progress no 
further without remaking the substrate with a secondary amide in place from an early stage. 
Scheme 17 - attempts to methylate the amino-amide substrates 
2.2. α-Phenyl amide substrates 
Attention turned next to the use of an aromatic group to lower the pKa alongside an imide as 
before. Phenylacetic acid 51 was converted to secondary amide 52 in good yield via the acyl 
chloride (Scheme 18). This was then converted to the trifluoroacetyl imide 53. The 
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trifluoroacetyl group is known to be highly electron-withdrawing (see Table 2) so it was hoped 
it would help bring the acidity of the CH2 group into a workable range; the chemical shift for 
the α-CH2 is 4.1 ppm which seemed promising when compared to TKP 12b (4.2 ppm). 
Scheme 18 - progress towards α-phenyl amide substrates 
 However, when subjected to Michael addition conditions, the already slightly unstable imide 
decomposed with some benzylamide 52 visible in the crude NMR spectrum. Use of the Boc 
group gave a much more stable imide 55 and this was tested with a variety of bases and 
Michael acceptors as summarised in Table 4. 
 
 
 
entry Michael acceptor (equiv) catalyst (mol%) result 
1 MVK (2.5) quinidine 3 (10) NR 
2 MVK (2.5) TMG (20) 41% 
3 MVK (10) TMG (30) 78% 
4 acrolein (2.5) TMG (20) NR 
5 methyl acrylate (2.5) TMG (20) NR 
6 nitro styrene (2.5) TMG (20) NR 
7 chalcone (2) TMG (30) NR 
8 MVK (10) 57 (10) NR 
9 nitro styrene (1.2) 57 (10) NR 
10 MVK (2.5) 58 (10) NR 
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Table 4 - results from Michael additions on an α-phenyl amide substrate 
The table shows that only TMG seemed to be basic enough to deprotonate substrate 55. 
Guanidines have a pKa of about 14 which is significantly different from the pKa of the cinchona 
alkaloids (pKa ~ 8). Increasing the amount of methyl vinyl ketone and the catalyst loading to 
30 mol% gave a good yield of 78%. However, using this catalyst, the only Michael acceptor 
which reacted was MVK; even acrolein, with its comparable reactivity, gave no reaction. The 
quinine thiourea catalyst 57 and benzyl protected catalyst 58 was tested to see whether the 
bifunctional mode of action would encourage the reaction, but no product was observed. 
Attention was next turned to whether chiral guanidines based on the cinchona alkaloids could 
be made. 
2.3. Synthesis of chiral guanidines 
There are a number of ways of making guanidines and a common technique is to generate 
them from the corresponding thioureas.37 Given the previous work done in the group using 
thioureas, this was chosen as the preferred route. The sulfur of the thiourea must be activated 
prior to its reaction with an amine and searching of the literature revealed a number of ways 
to do this. The first method attempted involved the use of copper(I) chloride to mediate the 
reaction. This method had the advantage of not requiring any highly toxic mercury salts. 
Terada and co-workers reported the reaction in 2007 and achieved some very high yields on 
thioureas with a binaphthyl backbone. Unfortunately, only decomposition was observed with 
thiourea 57 (Scheme 19). 38 
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Scheme 19 - attempted guanidine formation with CuCl  
The origin of the basicity of guanidines is the high electron density on the nitrogen atoms, due 
to mesomeric donation from the other nitrogen atoms, this means that the positive charge in 
the conjugate acid is also highly delocalised and therefore very stable (Scheme 20). It was 
therefore reasoned that if the electron density was increased further, then the basicity would 
be even more enhanced. This was especially appealing for us, because substrate 55 (Table 4) 
had proved to be at the threshold of reactivity with the simple TMG catalyst. 3,5-
Bis(trifluoromethyl)phenyl thiourea 57 was very electron-deficient but a p-methoxyphenyl 
(PMP) group would be expected to give a much more electron rich system. 
Scheme 20 – Resonance forms for the conjugate acid of TMG 
A model system was therefore conducted to test the formation of a PMP substituted 
guanidine. Benzylamine was converted to thiourea 60 (Scheme 21) in excellent yield using the 
appropriate isothiocyanate. Successful formation of guanidine 61 was achieved, albeit in low 
yield, with methyl iodide activation of the thiourea. 
Scheme 21 - model system for guanidine formation 
Returning to the cinchona alkaloids, epi-aminoquinine 62 (Scheme 22) was successfully 
synthesised using a Mitsunobu reaction and Staudinger reduction. This amine was then 
transformed into the thiourea using the same method as on the model system in good yield. 
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Scheme 22 - synthesis of PMP substituted thiourea 
A number of methods were attempted to transform thiourea 63 into a guanidine. The methyl 
iodide activation method gave only a trace amount of product as well as some of the 
eliminated product, p-anisidine. Another procedure, using copper sulfate-silica gel reported 
by Ramadas and Srinivasan was attempted.39 They managed to form guanidine 65 in good to 
excellent yields but unfortunately only decomposition of the starting material was observed 
with thiourea 63 (Scheme 23).  
Scheme 23 - CuSO4-mediated guanidine formation 
Use of the copper(I) chloride method as attempted on 57 was similarly unsuccessful with the 
PMP substituted thiourea 63. The apparent sensitivity of these substrates was making the 
synthesis of the guanidine far from straightforward. Despite the toxicity, it was decided to 
investigate the use of mercury(II) oxide in mediating the reaction. This is a very common 
technique for the transformation and a one-step method was tried.40 Some starting material 
63 was isolated from the reaction mixture, but no product 67 could be isolated from the 
remaining material (Scheme 24). 
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Scheme 24 - attempted guanidine formation with HgO 
Parallel to this work we saw potential for using a completely different substrate for the 
synthesis of chiral guanidines. Previous work in the group had involved the use of a range of 
chiral lithium amide bases. Diamine 70 (Scheme 26) was used in the kinetic resolution of 
advanced bicyclic systems in the synthesis of polyprenylated natural product (+)-clusianone.41 
It was hoped that this could be converted to a guanidine using a carbodiimide and this was 
successfully achieved on a very simple model system (Scheme 25). 
Scheme 25 - model system for guanidine formation with carbodiimide 
The same conditions were used on chiral diamine 70 (Scheme 26) and initially it was thought 
that reaction had occurred, however the diamine and DCC had just co-eluted from the column 
in a precisely 1:1 ratio. Despite harsh conditions and even with the addition of an iron(II) 
acetate Lewis acid, as reported by Pottabathula and Royo in their synthesis of guanidines, no 
reaction occurred between diamine 70 and the carbodiimide.42 
Scheme 26 - attempted guanidine formation with carbodiimide 
Alternative routes to the guanidine, not including the thiourea intermediate, were also 
explored. Mitsunobu reactions with guanidine equivalents have been reported, meaning that 
there was potential for catalysts to be made directly from the cinchona alkaloids. Kozikowski 
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and co-workers reported in 1994 that bis(Boc)-protected guanidine 72 can undergo a high 
yielding Mitsunobu reaction with alcohols. 43 
Scheme 27 - Kozikowski’s method for guanidine formation 
Even more promising is the report by Rossiter et al that N,N′-bis-tert-butoxycarbonylpyrazole-
1-carboxamidine 73 can be used in a Mitsunobu reaction with the pyrazole group 
subsequently substituted by aryl amines (Scheme 28).44 This could allow for the generation of 
the PMP substituted guanidine which was our original target. 
Scheme 28 - Rositer’s synthesis of aryl guanidines 
This technique first required the synthesis of 75 from 1H-pyrazole-1-carboxamidine 
hydrochloride 74. This was carried out although the product was difficult to isolate cleanly and 
the subsequent Mitsunobu reaction with quinine gave a complex mixture with no product 76 
isolated.  
Scheme 29 - attempted synthesis of chiral guanidine 
To overcome this challenge it was decided to do a direct substitution of amino-quinine 62 with 
1H-pyrazole-1-carboxamidine hydrochloride, which was completed in excellent yield to finally 
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yield a chiral guanidine (Scheme 30). This guanidine was then used as a catalyst for a Michael 
addition on α-phenyl amide 55. Unfortunately no reaction occurred and the starting material 
was recovered after 24 h. This result indicates that the additional electron donating group of 
the PMP group may in fact be necessary to successfully catalyse this reaction. 
Scheme 30 - synthesis and use of a chiral guanidine catalyst 
In summary, extensive work has been done to access chiral guanidines. A number of reagents 
were tried in an attempt to convert a thiourea to a guanidine. The methyl iodide activation 
route was successful on a model system but gave no product on the actual system. The use of 
guanidine equivalents was not initially productive until one simple guanidine of quinine was 
synthesised, however it was not effective as a catalyst. Additional work was carried out on 
whether chiral diamine 70 (Scheme 26) could be transformed into a guanidine as had been 
achieved on a model system, but the diamine proved resistant to guanidine formation. 
2.4. Hydantoin substrates 
Hydantoins could be considered the five-membered analogue of the TKPs already in use in the 
research group. They contain one amide nitrogen and one imide nitrogen. There are no 
reported pKa values for acidity of the C-H bond (the imide N-H bond has a pKa value of 15.0 in 
unsubstituted hydantoin 7945). Whilst we would not expect it to be as acidic a substrate as the 
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TKP, as there is no possibility for any aromaticity in the conjugate base, it looked like it had 
potential for use in organocatalytic Michael additions. 
Scheme 31 - synthesis and test of bis-benzyl hydantoin 
Hydantoin 79 (Scheme 31) was first protected as bis-benzyl hydantoin 80 and tested in a 
Michael addition reaction with MVK. No reaction was observed with either quinidine 3 or the 
more basic TMG suggesting that the substrate was not acidic enough to react with the 
catalysts. Using an electron-withdrawing protecting group, such as Boc, was the next obvious 
step to see if hydantoins could still be utilised in Michael additions. The chemical shift of the 
CH2 group increased from 3.65 ppm to 4.24 ppm on switching from the benzyl groups to Boc 
groups, suggesting a noteworthy increase in acidity. This new hydantoin 82 was then tested 
with a number of bases and Michael acceptors (Table 5). 
entry Michael acceptor catalyst result 
1 MVK quinidine NR 
2 MVK TMG NR 
3 acrolein TMG NR 
4 nitro styrene TMG NR 
5 MVK 57 NR 
6 MVK MgBr2/DIPEA NR 
Table 5 - results from synthesis and tests of bis-Boc hydantoin 
Similar to the benzyl system, no reaction was observed with either quinidine or TMG. Other 
Michael acceptors were tried but these gave the same result. Thiourea catalyst 57 did not give 
any product either. Coltart and co-workers reported in 2008 that magnesium bromide and 
iPr2NEt could be used to promote soft-enolate formation.46 They formed the soft enolates of 
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ketones and then reacted them with acylating agents. Whilst no examples of Michael 
additions were reported, it was hoped that the same soft enolisation technique could be used 
on bis-Boc hydantoin 82. However when this reaction was tried on hydantoin 82 only some 
decomposition and unreacted starting material were observed. 
In order to enhance the acidity of the substrate it was hypothesised that it might be possible 
to make use of conjugate base aromaticity in the hydantoin. If the lactim ether 85 (Scheme 
32) could be formed then the conjugate base 86 would resemble imidazole, presumably with 
some of the associated aromatic stability. 
Scheme 32 - proposed route to lactim ether substrate 
A large quantity of the mono protected hydantoin 87 had been recovered from the synthesis 
of bis-benzyl hydantoin 80 and this was successfully transformed into lactim ether 88 (Scheme 
33). However when subjected to the Michael addition conditions using catalytic triethylamine, 
no reaction was observed and the starting material was recovered. 
Scheme 33 - synthesis and test of lactim ether substrate 
Having had little success with these modified hydantoins (80, 82 and 88), it was next 
investigated whether the hydantoins would undergo an aldol condensation to give 
unsaturated compound 91 (Scheme 34). This, it was thought, would then give a more acidic 
compound as the negative charge would be more delocalised in the conjugate base 92. A 
further advantage was that a Michael addition would generate a quaternary stereogenic 
centre thus avoiding any potential for racemisation under the reaction conditions. 
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Scheme 34 - proposed route to unsaturated hydantoin substrates 
A range of conditions were attempted for the aldol condensation with both of the hydantoins 
previously synthesised. Successful aldol reaction of TKP 12b had proved elusive in the group 
for some time, likely due to the reversibility of the process and competitive retro-aldol 
reaction for such an acidic compound. The results are summarised in Table 6. 
Table 6 - results from attempted synthesis of unsaturated hydantoins 
Milder alkoxide or acetate conditions gave a complex mixture with bis-Boc hydantoin 81 and 
no reaction with bis-benzyl hydantoin 80. Stronger bases were used with the benzyl substrate 
and the best results gave only trace amounts of the product. It was reported in 2013 by Britton 
and co-workers that aldol reactions of Boc-protected hydantoins can undergo a 1,3 migration 
of a Boc protecting group from the nitrogen to the oxygen; however there was no evidence of 
this having occurred in the above reactions.47 
With these difficulties in accessing a successful substrate for the Michael additions of 
hydantoins this was proving a challenging system to work on, attention therefore turned to 
more promising substrates. 
entry hydantoin conditions aldehyde result 
1 82 tBuOK, tBuOH acetaldehyde complex mixture 
2 82 AcONa, Ac2O benzaldehyde complex mixture 
3 80 AcONa, Ac2O benzaldehyde SM 
4 
80 LHMDS, THF acetaldehyde 
SM and trace of 
product 
5 
80 LDA acetaldehyde 
SM and trace of 
product 
6 
80 LHMDS, THF isobutyraldehyde 
SM and trace of 
product 
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2.5. Thalidomide substrates 
Thalidomide 94 (Figure 2) came to our attention because it is well documented that this drug 
racemises under physiological conditions.48 It was hoped that the acidic nature of the 
compound would allow for its use in cinchona organocatalysis.  
Figure 2 - thalidomide 
Work has been published on methylating49 and fluorinating50 at the 3-position of thalidomide 
which would prevent any racemisation. Further work has been reported on making 
configurationally stable thalidomides with methyl, phenyl48 or trifluoromethyl51 substituents 
in the 4-position. The phthalimide group is much more stable trans to these substituents, so 
a configurationally stable thalidomide derivative is formed.  
To the best of our knowledge, organocatalytic Michael additions had not been done before 
on 94 and the reported pKa of 12.5 means that it should be an amenable substrate for such 
reactions.52 Michael addition products could then be treated with hydrazine to remove the 
phthalimide group and yield chiral imide 96 (Scheme 35). 
Scheme 35 - proposed Michael addition with thalidomide 
The synthesis of thalidomide 94 was relatively straightforward as L-glutamine could be 
condensed with phthalic anhydride. The addition of thionyl chloride generates the acyl 
chloride which reacts with the amide to close the glutarimide ring (Scheme 36).  
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To our surprise no reaction was observed under the Michael addition conditions with 
triethylamine. In order to further enhance the acidity of the substrate and hopefully provoke 
a reaction, the glutarimide was protected with an electron withdrawing Boc group to give 97 
(Scheme 36). However, no reaction was observed with methyl vinyl ketone in the presence of 
either triethylamine or TMG. The origin of this low reactivity was assumed to be the steric 
congestion at the reactive carbon. The glutarimide ring will prefer to be orientated out of the 
plane of the phthalimide and therefore will block approach of the Michael acceptor from 
either face. 
Scheme 36 - synthesis and test of thalidomide substrates 
2.6. Phenyl-TKP substrates 
Following the limited success of the acyclic, hydantoin and thalidomide type systems for 
organocatalytic Michael additions, our attention returned to the TKP system which had 
previously worked so effectively in the group (Section 1.3). We had already explored the effect 
a phenyl group could have in lowering the pKa of substrates so we began to explore the 
possibility of having an aromatic group on the acidic carbon of the TKP.  
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The first generation synthesis of the desired TKP used phenylglycine 99 (Scheme 37) as the 
starting material. It was used in racemic form and is very cheap despite not being a naturally 
occurring amino acid. The carboxylic acid needed to be converted to an amide; to prevent self-
condensation in this process, the amine group was first protected as the Boc derivative 100 in 
good yield. The carboxylic acid was then activated with ethyl chloroformate and benzylamine 
was added to generate the amide 101 in excellent yield. Deprotection of the amine with TFA 
was followed by reductive amination with benzaldehyde which gave the required amino 
amide 103. The group method for cyclisation was used and the amino amide was heated with 
oxalyl benzotriazole in the microwave at 150 °C for 1 h to give 104 in moderate yield. 
Scheme 37 - synthesis of phenyl-TKP 
Given the number of steps involved in making phenyl-TKP 104 the prospect of a direct coupling 
of an aryl group to the simple TKP 12b seemed appealing. Baran and co-workers have reported 
the oxidative coupling of indole and pyrrole with ketones, esters and amides.53 Scheme 38 
shows a further example with an oxazolidinone substrate 105. 
Scheme 38 - Baran’s oxidative cross-coupling with indole 
Application of this methodology to TKP 12b was unsuccessful and a complex mixture was 
observed after the reaction (Scheme 39).  
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Scheme 39 - attempted cross-coupling with indole 
Kwong and co-workers have used copper catalysis to couple aryl halides to simple malonates 
and this result was successfully replicated in our hands. The optimal ligand was reported to be 
2-picolinic acid and the reaction proceeded at room temperature in high yield (Scheme 40).54 
Scheme 40 - Kwong’s CuI-catalysed arylation 
These conditions were attempted on our TKP substrate 12b but unfortunately only 
decomposition of the starting material was observed (Scheme 41). This was surprising because 
of the very mild conditions involved. 
Scheme 41 - attempted arylation with CuI 
A further idea for the phenylation of TKP 12b was to use a hypervalent iodine species. 
Aggarwal and Olofsson reported in 2005 that they could perform an α-arylation of a ketone 
using diphenyliodonium triflate (DPIT) and a lithium base. They further report that this could 
be done asymmetrically when chiral bases were employed. For their simple cyclohexanone 
substrate yields of 83% were achieved with 2 equivalents of base required to allow for the 
second deprotonation after the arylation had occurred (Scheme 42).55 
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Scheme 42 - Aggarwal’s phenylation with DPIT 
The DPIT salt 108 was easily synthesised using a procedure published by Olofsson and co-
workers which uses mCPBA as the oxidant (Scheme 43). This procedure allows for the 
synthesis of a wide range of diaryl iodonium salts so long as the aryl iodide is accessible.56 
Scheme 43 - synthesis of DPIT 
With iodonium salt 108 in hand, the reported conditions were attempted on TKP 12b and were 
initially unsuccessful with decomposition occurring. Switching to an amine base at warmer 
temperatures did yield some of the desired product. Extensive optimisation was carried out 
to increase this yield as summarised in Table 7. 
entry base 
(equiv) 
DPIT 
(equiv) 
solvent time (h) temperature yield (%) 
1 LHMDS (2) 1.0 THF 3 −78 °C to −45 °C decomposition 
2 K3PO4 (2.5) 1.0 THF 18 rt decomposition 
3 NEt3 (1.1) 1.3 CH2Cl2 16 0 °C to rt 26 
4 NEt3 (2.5) 1.2 CH2Cl2 18 0 °C to rt 17 
5 NEt3 (1.1) 1.1 CH2Cl2 6 0 °C to rt 33 
6 NEt3 (1.1) 1.1 CH2Cl2 72 0 °C to rt 41 
7 NEt3 (1.05) 1.05 CH2Cl2 19 0 °C to rt 48 
Table 7 - results from DPIT phenylations 
Increasing the amount of base and electrophile appeared to be detrimental to the yield and it 
was unclear whether there was any loss of product over long reaction times. Whilst no 
exceptional yields were achieved, this is a much more efficient route than the previous 
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synthesis outlined above (Scheme 37). Furthermore starting material could be recovered from 
this reaction to be used in successive arylations (for example, in entry 6, 23% of the starting 
material was recovered). 
With promising substrate 104 now available, work began on the organocatalytic Michael 
additions. MVK was chosen as the test acceptor and a range of catalysts were used. Table 8 
shows the results achieved. 
entry catalyst time (h) yield (%) era 
1 NEt3 24 50 - 
2 quinine 2 19 42 72:38 
3 quinidine 3 27 77 30:70 
4 63 27 63 50:50 
5 58 6 75 9:91 
a determined by HPLC analysis 
Table 8 - results from the Michael additions of phenyl-TKP 
Pleasingly the Michael additions proceeded in good to moderate yield. The reaction was 
relatively slow with some starting material remaining after 24 h making chromatography 
difficult and contributing further to some of the lower yields. The natural cinchona catalysts 
(2 and 3) gave enantiomeric products, as would be predicted, with only a relatively low er. 
Interestingly the thiourea catalyst 63 (Scheme 22) gave a racemic mixture. The most successful 
catalyst 58 (Table 4) had the C-9 secondary alcohol protected with a benzyl group and a free 
quinoline hydroxyl. The reaction was much faster with this catalyst and respectable yields and 
selectivities were observed.  
Interestingly, whilst catalyst 58 was a derivative of quinine, it gave the opposite selectivity to 
natural quinine 2 suggesting that the free hydroxyl might be fundamental to the catalyst 
reactivity.  This is supported by the stereochemical model suggested by Deng and co-workers. 
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They suggest that the catalyst adopts a gauche-open conformation (Scheme 44) that allows 
for the simultaneous activation of the acceptor and substrate.57,58 As can be seen from the 
model, the quinuclidine acts as base to deprotonate the TKP with a hydrogen bond developing 
between them. The quinoline hydroxyl activates the Michael acceptor through a hydrogen 
bond and directs the acceptor to the lower face of the planar TKP. This model would therefore 
predict an absolute R stereochemistry for the product although this hypothesis needs to be 
confirmed by X-ray crystallography.  
Scheme 44 - stereochemical model for cinchona-catalysed Michael addition 
These exciting preliminary results have the potential for future optimisation of the reaction 
conditions, including the catalyst design, as well as opportunities to broaden the scope of the 
reaction. 
2.7. PMB-protected phenyl-TKP substrates 
In order to develop these asymmetric reactions, further transformations will need to be 
carried out on the TKP products. This could be reduction to the DKP which is a ‘privileged 
structure’ among natural products and in medicinal chemistry. Breaking apart the ring to 
unmask an α-amino acid would also be highly desirable. 
Protecting groups are required on the TKP for the Michael additions to prevent reaction on 
the nitrogen atoms. However these groups quickly become redundant and may hinder 
attempts at further transformations. Having labile groups therefore became appealing to us. 
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Benzyl groups can normally be removed under hydrogenolysis conditions, however, the 
phenyl group on TKP 104 is also ‘benzylic’ with respect to the amide nitrogen. Para-
methoxybenzyl (PMB) groups were chosen as an alternative protecting group, as it was hoped 
that they could be removed selectively due to their propensity to be oxidised. One example 
of this is in Mukaiyama and co-workers’ total synthesis of Taxol® where they report that a 
PMB ether could be cleaved in the presence of a benzyl ether with DDQ.59  
The synthesis of these PMB protected TKPs was conducted using the more lengthy technique 
shown previously for the benzyl TKP in Scheme 35. This was because investigations into the 
hypervalent iodine arylations reported above were still ongoing. Following Boc protection, the 
amino acid was converted to amide 110, this time using isobutyl chloroformate to form the 
mixed anhydride intermediate (Scheme 45). TFA was then used to cleave the Boc group in 
high yield and reductive amination with anisaldehyde gave amino amide 112. The cyclisation 
with oxalyl benzotriazole proceeded to give PMB protected TKP 113. 
Scheme 45 - synthesis of PMB-protected TKP 
TKP 113 was then used in a number of Michael additions with ketones and an aldehyde. The 
most successful catalyst for the benzyl-protected TKP substrate 104 was the OBn modified 
quinine 58 and this was used again. The results of the asymmetric reactions are summarised 
in Table 9. 
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entry R time (h) yield (%) era 
1 Me 72 quant 93:7 
2 Ph 21 91 87:13 
3 Cy 45 96 93:7 
4 Et 20 quant 94:6 
5 H 72 43 59:41b 
a determined by HPLC analysis  
b HPLC performed on an acetal derivative  
Table 9 - results from the Michael additions of PMB-protected TKP 
The four ketones tested gave excellent selectivities with ethyl vinyl ketone giving the highest; 
acrolein gave a much reduced selectivity. Acrolein needed to be converted to the acetal for 
HPLC analysis but it is not clear why the yield and selectivity were eroded with this acceptor. 
As would be predicted the more reactive phenyl vinyl ketone proceeded to completion faster 
than cyclohexyl vinyl ketone. 
These results represent the successfully development of asymmetric organocatalytic Michael 
additions to phenyl substituted TKPs. High selectivities and yields have been achieved for a 
range of unsaturated ketones. Initial work on further transformations focussed on trying to 
remove the PMB group from the TKP. 
Numerous methods of PMB group removal have been reported and a number were attempted 
with the results summarised in Table 10. Probably the most common method in the literature 
is to use ceric ammonium nitrate (CAN). A procedure published by Corey and co-workers was 
attempted on TKP 113, but no product was isolated from the reaction with starting material 
recovered and a small amount of anisaldehyde.60 Martin and co-workers report the use of 
neat TFA to remove a PMB group from an amide; however no reaction was observed for our 
system using this technique.61 Jung and Lyster published a procedure using trimethylsilyl 
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iodide but again this was ineffective on our TKP and the starting material was fully recovered.62 
Returning to the oxidative methods, a technique using potassium peroxydisulfate was 
attempted. Podlech and Linder had reported the removal of a PMB group from a lactam in 
moderate yield using these conditions but only decomposition could be observed on our TKP 
system along with some anisaldehyde by-product.63 The final technique tried was the use of 
DDQ as reported by Davies and co-workers, however no reaction was observed with this 
reagent.64  
entry reagent solvent temperature (°C) time (h) yield  
1 CAN MeCN/H2O 0 to rt 24 SM and some PMPCHO 
2 TFA - rt 24 100% recovery of SM 
3 TMSI CDCl3 rt-50 24 100% recovery of SM 
4 K2S2O8 MeCN/H2O 75 4 decomposition  
5 K2S2O8 MeCN/H2O 75 2 decomposition 
6 DDQ DCM rt 25 94% recovery of SM 
Table 10 - results from attempted PMB removal 
These preliminary tests have not found a successful technique for the removal of the PMB 
group. Varying the temperature has yet to be explored and the use of other protecting groups 
such as allyl groups could also be investigated. 
2.8. Conclusions and future work 
Investigations have been carried out on organocatalytic Michael additions. Synthesising 
suitable substrates for this type of reaction proved more difficult than expected, and some 
substrates proved entirely unreactive including the hydantoins (Section 2.4) and thalidomide 
(Section 2.5). Other substrates reacted in unexpected ways (amino-borane 46, Section 2.1). 
TMG showed limited success in catalysing the Michael additions of α-phenyl amide 55 (Section 
2.2) but only with MVK as the Michael acceptor. This prompted further work on generating 
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highly-basic chiral organocatalysts. A number of methods were attempted to make a PMP-
substituted guanidine attached to cinchona alkaloid. The use of thiourea intermediates was 
unsuccessful and the only chiral guanidine that could be generated was devoid of the extra 
electron-donating PMP group. 
More success was achieved with the TKP substrates and the focus was on TKPs with a phenyl 
substituent at the reactive centre. A novel synthesis was devised which used a 
diphenyliodonium salt to arylate TKP 12b (Scheme 46). This significantly shortened the 
synthesis of these substrates and would allow for alternative aryl groups to be easily 
introduced. Further work will include optimisation of the yield for this reaction and also 
broadening the scope. It may also be possible to perform the arylation asymmetrically if a 
chiral base is used. 
Scheme 46 - succesful phenylation of TKP 
With the phenyl substituted TKP in hand, a range of Michael additions were tested and the 
optimal catalyst was found to be 58 with a free quinoline hydroxyl and the secondary alcohol 
protected. The reactions were relatively slow at rt and further work is needed to complete the 
optimisation of both yield and selectivity. Further work would also include crystallisation of 
Michael adduct 109 to allow for the absolute configuration to be determined by X-ray 
crystallography. 
Scheme 47 - Michael addition with phenyl-TKP 
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With a view to their subsequent removal, TKP 113 was synthesised with PMB protecting 
groups. This was found to perform better as a substrate and excellent yields and selectivities 
were achieved with unsaturated ketone acceptors (Scheme 48). 
Scheme 48 - Michael addition with PMB-protected TKP 
There is potential for the scope of this reaction to be increased to other classes of Michael 
acceptors. Work focussed on the removal of the PMB groups has so far not been fruitful, 
making this an area for future work or alternatively trying a different protecting group entirely.  
Removal of the oxalyl component of the TKP would be appealing as it would reveal amino acid 
equivalents with unusual quaternary stereocenters (Scheme 49). These may find applications 
in making synthetic proteins with finely tuned properties.  
Scheme 49 - proposed ring-opening of TKP 
In summary the project aims of investigating the scope of asymmetric organocatalytic Michael 
additions on amide-like systems have been achieved. The acyclic systems were largely not 
suitable substrates and the hydantoins and thalidomide were also not amenable to 
organocatalysis. However, excellent results have been reported for the synthesis of phenyl 
TKPs and the organocatalysed Michael additions with ketones with some quantitative yields 
and er values up to 94:6. 
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3. EXPERIMENTAL 
3.1. General experimental techniques 
Solvents and Reagents 
All reaction solvents were acquired from the Innovative Technology solvent purification 
system except for acetone which was dried for a minimum of 3 h over 3 Å molecular sieves. 
Commercially available reagents were used as supplied except NEt3 which was distilled from 
CaH2 and stored over NaOH pellets and under nitrogen. Petrol refers to the fraction of 
petroleum ether boiling between 40 and 60 °C and was used interchangeably with hexane. All 
anhydrous reactions were carried out in oven-dried glassware and under an atmosphere of 
nitrogen. 
Chromatographic Techniques 
Thin layer chromatography was carried out using Merck aluminium-backed silica gel 60 F254 
plates. Spots were then visualised by quenching with ultraviolet light (λ max 254 nm) and then 
stained and heated with either anisaldehyde or potassium permanganate solutions as 
appropriate. Flash column chromatography was performed using Merck Geduran Silica (40-64 
µm) unless otherwise stated and the solvent system is reported in brackets. 
High Performance Liquid Chromatography 
HPLC analysis was performed using a P580 Dionex pump and Chromeleon Client software. The 
columns used were the Chiralpak AD and OD columns (250 x 4.6 mm) from Daicel Chemical 
Industries Ltd. Detection was with a Waters 996 photodiode array detector using UV light (210 
and 220 nm). 
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Infrared Spectroscopy 
Infrared spectra were recorded using a Perkin Elmer Spectrum 100 FT-IR spectrometer. 
Absorption maxima (νmax) are reported in wavenumbers (cm-1) and are described as strong (s), 
medium (m), weak (w) or broad (br). 
Nuclear Magnetic Resonance Spectroscopy  
Proton (1H) (300 and 400 MHz) and carbon (13C) (100 MHz) spectra were recorded on Bruker 
Avance III 300 MHz and Bruker Avance III 400 MHz spectrometers. Chemical shifts (δH or δC) 
are reported in parts per million (ppm) downfield of tetramethylsilane using residual solvent 
as an internal reference. Assignments are made on the basis of chemical shifts, integrations 
and coupling constants, using COSY, HSQC, HMBC and NOE experiments where appropriate. 
Multiplicities are described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), 
apparent (app) and broad (br) or combinations thereof. Coupling constants (J) are reported to 
the nearest 0.5 Hz. 
Melting Points 
Melting points were recorded on a Gallenkamp melting point apparatus used with a Hanna 
digital thermocouple thermometer and are uncorrected. Literature values for known 
compounds are from the overall reference given for the compound unless otherwise stated.  
Mass Spectrometry 
Novel compounds were analysed by means of the Synapt G2-S HDMS system (Waters, 
Manchester, UK). All experimental data was acquired with a resolution of 20,000 and samples 
were introduced into the mass spectrometer via the nanoAcquity system (Waters, 
Manchester, UK). Electrospray ionisation was performed with a capillary voltage of 3.2 
kilovolts, and the sample cone was set at 40 volts. Mass to charge ratios (m/z) are reported in 
Daltons and the percentage abundance is given in brackets. High resolution mass 
spectrometry data is recorded to four decimal places. 
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Polarimetry 
Asymmetric samples were analysed using PolAAr 2001 polarimeter (Optical Activity Ltd) and 
optical rotations are recorded in units of 10-1 deg cm2 g-1 with the concentration (g/100 mL), 
solvent and temperature. 
3.2. Compounds 
2-Azidoacetamide 3965 
2-Chloroacetamide 38 (124 mg, 1.33 mmol) was added to a solution of sodium azide (259 mg, 
3.98 mmol) in H2O (2.5 mL). The reaction mixture was then stirred at 60 °C for 24 h before 
being cooled to rt, diluted with H2O (40 mL) and extracted with EtOAc (3 x 30 mL). The 
combined organic layers were dried with Na2SO4 and concentrated under reduced pressure. 
Purification by recrystallisation from CH2Cl2 afforded azide 39 as white crystals (126 mg, 95%). 
Rf 0.56 (3:1 EtOAc/MeOH); m.p. 56-57 °C (lit. 55-56 °C); 1H NMR (300 MHz, CDCl3): δ 3.96 (2H, 
s, CH2), 6.44 (1H, br s, NHH’), 6.77 (1H, br s, NHH’); 13C NMR (100 MHz, CDCl3): δ 52.2 (CH2), 
169.9 (CO); IR (neat) νmax/cm-1 3373m, 3184m, 2108s (azide), 1624s, 1412s, 1314s, 1270m, 
1095m, 957w.  
tert-Butyl (2-azidoacetyl)carbamate 41 
Synthesised according to the literature procedure.66 A solution of azido amide 39 (224 mg, 
2.24 mmol) in THF (6.5 mL) was added to a suspension of NaH (60% in mineral oil, 116 mg, 
2.91 mmol) in THF (6.5 mL) at 0 °C. The reaction mixture was warmed to rt then cooled back 
to 0 °C and di-tert-butyl dicarbonate (1.0 M solution in THF, 3.13 mL, 3.13 mmol) was added. 
After 30 min the reaction mixture was warmed to rt and stirred for 24 h. It was then quenched 
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with saturated aqueous NH4Cl (50 mL) and extracted with Et2O (4 x 40 mL). The combined 
organic layers were washed with brine (100 mL), dried with Na2SO4 and concentrated under 
reduced pressure. Purification by flash column chromatography (6:1 petrol/Et2O) afforded Boc 
amide 41 as a white solid (155 mg, 33%). Rf 0.58 (1:1 petrol/EtOAc); m.p. 70-72 °C; 1H NMR 
(300 MHz, CDCl3): δ 1.49 (9H, s, C(CH3)3), 4.35 (2H, s, CH2), 7.85 (1H, s, NH); 13C NMR (100 MHz, 
CDCl3): δ 27.9 (C(CH3)3), 52.9 (CH2), 83.6 (C(CH3)3), 150.1 ((NC(O)O), 169.5 (NC(O)CH2); IR (neat) 
νmax/cm-1 3216m, 2975m, 2117s (azide), 1750s, 1705s, 1691s, 1490s, 1368s, 1229s, 1148s, 
1075s, 941m; m/z (ES+) 223.1 ([M+Na]+, 100%), 167.0 ([CONHBoc+Na]+, 40%); HRMS (ES+) 
223.0811 [M+Na]+, C7H12N4O3Na requires 223.0807. 
2-(Diethylamino)acetamide 43 
Synthesised according to the literature procedure.67 A solution of diethylamine (26.7 mL, 258 
mmol) in EtOH (50 mL) was added to a suspension of 2-chloroacetamide 38 (11.0 g, 117 mmol) 
and KI (21.4 g, 129 mmol) in EtOH (450 mL) and was then heated under reflux. After 3 h, the 
reaction mixture was cooled to rt and 90% of the solvent was removed under reduced 
pressure. The residue was diluted with H2O (500 mL) and extracted with Et2O (3 x 400 mL). 
The combined organic layers were dried with Na2SO4 and concentrated under reduced 
pressure to afford amino amide 43 as an off-white powder (5.92 g, 39%). Rf 0.38 (3:1 
EtOAc/MeOH); m.p.  72-74 °C; 1H NMR (300 MHz, CDCl3): δ 0.99 (6H, t, J = 7.0 Hz, 2 x CH3), 
2.52 (4H, q, J = 7.0 Hz, 2 x CH2), 2.96 (2H, s, C(O)CH2), 6.65 (1H, br s, NHH’), 7.22 (1H, br s, 
NHH’); 13C NMR (100 MHz, CDCl3): δ 12.2 (2 x CH3), 48.5 (2 x CH2), 57.3 (C(O)CH2), 175.7 
(C(O)NH2); IR (neat) νmax/cm-1 3379s(br), 3173s(br), 2970s, 2932m, 2821m, 1649s, 1453m, 
1399s, 1368s, 1340s, 1286m, 1257m, 1204m, 1064s; m/z (ES+) 131.1 ([M+H]+, 65%); HRMS 
(ES+) 131.1183 [M+H]+, C6H15N2O requires 131.1184. 
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tert-Butyl (diethylglycyl)carbamate 44 
Synthesised according to the literature procedure.66 A solution of amino amide 43 (1.50 g, 
11.5 mmol) in THF (50 mL) was added to a suspension of NaH (60% in mineral oil, 553 mg, 13.8 
mmol) in THF (50 mL) at 0 °C. The reaction mixture was warmed to rt then cooled back to 0 °C 
and di-tert-butyl dicarbonate (1.0 M solution in THF, 12.7 mL, 12.7 mmol) was added. After 30 
min the reaction mixture was warmed to rt and stirred for 1 h. It was then quenched with 
saturated aqueous NH4Cl (200 mL) and extracted with Et2O (4 x 150 mL). The combined organic 
layers were washed with brine (400 mL), dried with Na2SO4 and concentrated under reduced 
pressure. Purification by flash column chromatography (6:1 petrol/EtOAc, 2% NEt3) afforded 
Boc amide 44 as a white powder (1.37 g, 52%). Rf 0.59 (3:1 EtOAc/MeOH); m.p. 39-41 °C; 1H 
NMR (300 MHz, CDCl3): δ 1.06 (6H, t, J = 7.0 Hz, 2 x CH3), 1.52 (9H, s, C(CH3)3), 2.60 (4H, q, J = 
7.0 Hz, 2 x CH2), 3.10 (C(O)CH2), 9.35 (1H, br s, NH); 13C NMR (100 MHz, CDCl3): δ 12.1 (2 x 
CH3), 28.0 (C(CH3)3), 48.7 (2 x CH2), 58.1 (NCH2), 82.2 (C(CH3)3), 149.4 (NHC(O)O), 170.9 
(NHC(O)CH2); IR (neat) νmax/cm-1 3297w, 2972m, 2877w, 1786s, 1719s, 1478s, 1466s, 1368s, 
1311m, 1246m, 1133s; m/z (ES+) 231.2 ([M+H]+, 9%), 253.2 ([M+Na]+, 9%), 483.3 ([2M+Na]+, 
100%); HRMS (ES+) 231.1705 [M+H]+, C11H23N2O3 requires 231.1709. 
tert-Butyl (diethylglycyl)carbamate borane complex 46 
Synthesised according to the literature procedure.33 BH3·SMe2 (275 µL, 2.90 mmol) was added 
dropwise over 2 min to a solution of amino amide 44 (637 mg, 2.77 mmol) in THF (5.5 mL) at 
−78 °C. After 90 min the reaction was quenched with H2O (1.5 mL) and warmed to rt. The 
mixture was then poured into a separating funnel with H2O (150 mL) and Et2O (150 mL) and 
separated. The aqueous phase was extracted with Et2O (150 mL) and the combined organic 
layers were washed with 2 N HCl (200 mL) and brine (200 mL). The organic phase was then 
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dried with MgSO4 and concentrated under reduced pressure to afford amino borane 46 (582 
mg, 86%). Rf 0.72 (3:1 EtOAc/MeOH); m.p. 44-46 °C; 1H NMR (300 MHz, CDCl3): δ 1.27 (6H, t, 
J = 7.0 Hz, 2 x CH3), 1.51 (9H, s, C(CH3)3), 3.02-3.17 (2H, m, CH2CH3), 3.18-3.33 (2H, m, CH2CH3), 
3.92 (2H, s, NCH2), 7.54 (1H, br s, NH). BH3 protons not observed; 13C NMR (100 MHz, CDCl3): 
δ 9.4 (2 x CH3), 27.9 (C(CH3)3), 54.8 (2 x CH2CH3), 57.2 (NCH2), 83.6 (C(CH3)3), 149.5 (NC(O)O), 
167.8 (NC(O)CH2); IR (neat) νmax/cm-1 3275w, 2980w, 2382w (B-H), 2329w (B-H), 2284w (B-H), 
1754m, 1510m, 1369m, 1254m, 1137s, 987m; m/z (ES+) 231.2 ([M+H-BH3]+, 100%); product 
unstable in gas phase so no molecular ion peak observed. 
tert-Butyl (diethylglycyl)(3-oxobutyl)carbamate borane complex 47 
Tetramethylguanidine (9 µL, 0.070 mmol) was added to a solution of amino borane 46 (60 mg, 
0.246 mmol) in CH2Cl2 (0.75 mL). Next methyl vinyl ketone (50 µL, 0.614 mmol) was added 
dropwise over 1 min and the reaction mixture was stirred at rt for 18 h. Solvent was 
evaporated under reduced pressure and flash column chromatography (3:1 petrol/EtOAc) 
afforded Michael adduct 47 as a colourless oil (22 mg, 29%). Rf 0.58 (3:1 EtOAc/MeOH); 1H 
NMR (400 MHz, CDCl3): δ 1.23 (6H, t, J = 7.0 Hz, 2 x CH2CH3), 1.54 (9H, s, C(CH3)3), 2.16 (3H, s, 
C(O)CH3), 2.68 (2H, t, J = 7.5 Hz, NCH2CH2), 3.03-3.15 (2H, m, CH2CH3), 3.21-3.33 (2H, m, 
CH2CH3), 3.92 (2H, t, J = 7.5 Hz, NCH2CH2), 4.07 (2H, s, C(O)CH2), BH3 protons not observed; 13C 
NMR (100 MHz, CDCl3): δ 9.5 (2 x CH2CH3), 27.9 (C(CH3)3), 30.1 (C(O)CH3), 39.7 (NCH2CH2), 41.9 
(NCH2CH2), 54.5 (2 x CH2CH3), 57.4 (C(O)CH2), 84.8 (C(CH3)3), 152.1 (NC(O)O), 170.0 
(NC(O)CH2), 206.3 (C(O)CH3); IR (neat) νmax/cm-1 2977w, 2378m (B-H), 2333w (B-H), 2284w (B-
H), 1734m, 1713m, 1369s, 1350m, 1141s, 1054m; m/z (ES+) 301.2 ([M+H-BH3]+, 30%), product 
unstable in gas phase so no molecular ion peak observed. 
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N-Benzyl-2-phenylacetamide 5268 
Synthesised according to the literature procedure.69 Phenylacetic acid 51 (2.04 g, 15.0 mmol) 
was added to thionyl chloride (45.0 mL) and heated under reflux for 3 h and then concentrated 
under reduced pressure to afford the acyl chloride as a brown oil in quantitative yield.  
Benzylamine (708 µL, 6.48 mmol) and DMAP (158 mg, 1.23 mmol) were added to pyridine 
(550 µL, 6.81 mmol) in CH2Cl2 (11 mL) and cooled to −5 °C. The acyl chloride (1.05 g, 6.81 
mmol) was then added and the reaction mixture was warmed to rt and stirred for 3 h. The 
reaction mixture was then diluted with CH2Cl2 (350 mL) and washed with H2O (200 mL), 1 N 
HCl (200 mL), 5% aqueous solution of NaHCO3 (200 mL) and brine (200 mL). The organic phase 
was then concentrated under reduced pressure to afford amide 52 as pale orange flakes (1.14 
g, 78%). Rf 0.60 (EtOAc); m.p. 112-113 °C (lit. 118-119 °C); 1H NMR (300 MHz, CDCl3): δ 3.58 
(2H, s, CH2C(O)), 4.36 (1H, s, NCHH’), 4.38 (1H, s, NCHH’), 5.88 (1H, s br, NH), 7.12-7.36 (10H, 
m, 2 x Ph); 13C NMR (100 MHz, CDCl3): δ 43.5 (CH2CO), 43.7 (CH2NH), 127.3 (2 x CH, Ph), 127.4 
(2 x CH, Ph), 128.6 (2 x CH, Ph), 129.0 (2 x CH, Ph), 129.4 (2 x CH, Ph), 134.8 (C, Ph), 138.0 (C, 
Ph), 170.8 (C(O)); IR (neat) νmax/cm-1 3285m, 3032w, 1637s, 1548m, 1491w, 1453w, 1345w, 
1027m. 
N-Benzyl-2,2,2-trifluoro-N-(2-phenylacetyl)acetamide 53 
Trifluoroacetic anhydride (955 µL, 6.87 mmol) was added to a solution of amide 52 (515 mg, 
2.29 mmol), DMAP (112 mg, 0.91 mmol) and pyridine (833 µL, 10.31 mmol) in CH2Cl2 (17 mL). 
The reaction mixture was then stirred at rt for 2 h before brine (30 mL) and petrol (100 mL) 
were added. The layers were separated and the organic layer was washed with brine (3 x 50 
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mL), dried with MgSO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (10:1 petrol/Et2O) afforded imide 53 as an unstable dark brown oil (268 mg, 
36%). Rf 0.40 (4:1 petrol/Et2O); 1H NMR (300 MHz, CDCl3): δ 4.06 (2H, s, NCH2), 4.94 (2H, s, 
C(O)CH2), 7.08-7.34 (10H, m, 2 x Ph); 13C NMR (100 MHz, CDCl3): δ 44.5 (C(O)CH2), 47.9 (NCH2), 
115.8 (q, JC-F = 288 Hz, CF3), 126.4 (2 x CH, Ph), 127.6 (CH, Ph), 127.9 (CH, Ph), 128.8 (2 x CH, 
Ph), 128.9 (2 x CH, Ph), 129.4 (2 x CH, Ph), 132.6 (C, Ph), 135.3 (C, Ph), 160.0 (q, JC-F = 39 Hz, 
C(O)CF3), 173.9 (NC(O)); IR (neat) νmax/cm-1 3285m, 3063w, 3032w, 1636s, 1547s, 1491m, 
1453m, 1432m, 1345m, 1160m, 1026m; product unstable in gas phase so no mass spectrum 
could be obtained. 
tert-Butyl benzyl(2-phenylacetyl)carbamate 55 
Di-tert-butyl dicarbonate (109 µL, 0.474 mmol) and DMAP (2 mg, 0.020 mmol) were added to 
a solution of amide 52 (89 mg, 0.395 mmol) in THF (2.4 mL) at 0 °C. The reaction mixture was 
warmed to rt and after 18 h the solvent was removed under reduced pressure. The residue 
was then taken up in CH2Cl2 (40 mL) and washed with 2 N HCl (30 mL), saturated aqueous 
NaHCO3 (30 mL) and brine (30 mL). The organic layer was then dried with MgSO4 and 
concentrated under reduced pressure. Purification by flash column chromatography (10:1 
petrol/Et2O) afforded Boc amide 55 as a yellow oil (114 mg, 89%). Rf 0.62 (1:1 petrol/EtOAc); 
1H NMR (300 MHz, CDCl3): δ 1.48 (9H, s, C(CH3)3), 4.37 (2H, s, C(O)CH2), 4.98 (2H, s, NCH2), 
7.28-7.44 (10H, m, 2 x Ph); 13C NMR (100 MHz, CDCl3): δ 27.8 (C(CH3)3), 44.4 (C(O)CH2), 47.7 
(NCH2), 83.3 (C(CH3)3), 126.7 (CH, Ph), 127.1 (CH, Ph), 127.6 (2 x CH, Ph), 128.2 (2 x CH, Ph), 
128.3 (2 x CH, Ph), 129.6 (2 x CH, Ph), 135.1 (C, Ph), 138.1 (C, Ph), 153.0 (NC(O)O), 174.2 
(NC(O)CH2); IR (neat) νmax/cm-1 3032w, 2979w, 1731s, 1689m, 1455w, 1368m, 1355m, 1224m, 
1143s, 1078m, 1031w, 1016w; m/z (ES+) 348.2 ([M+Na]+, 100%); HRMS (ES+) 348.1581 
[M+Na]+, C20H23NO2Na requires 348.1576. 
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tert-Butyl benzyl(5-oxo-2-phenylhexanoyl)carbamate 78 
Tetramethylguanidine (5 µL, 0.04 mmol) was added to a solution of Boc amide 55 (44 mg, 
0.135 mmol) in CH2Cl2 (0.5 mL). Next methyl vinyl ketone (118 µL, 1.35 mmol) was added 
dropwise over 2 min and the reaction mixture was stirred at rt for 5 h. The solvent was 
evaporated under reduced pressure and flash column chromatography (15:1 to 5:1 
petrol/Et2O) afforded Michael adduct 78 as a colourless oil (38 mg, 78%). Rf 0.38 (1:1 
petrol/Et2O); 1H NMR (400 MHz, CDCl3): δ 1.30 (9H, s, C(CH3)3), 1.99-2.09 (1H, m, 
NC(O)CHCHH’), 2.07 (3H, s, C(O)CH3), 2.27-2.48 (3H, m, NC(O)CHCHH’ and CH3C(O)CH2), 4.74 
(1H, d, J = 15.0 Hz, NCHH’), 4.88 (1H, d, J = 15.0 Hz, NCHH’), 4.93-4.99 (1H, m, NC(O)CH), 7.07-
7.30 (10H, m, 2 x Ph); 13C NMR (100 MHz, CDCl3): δ 27.7 (C(CH3)3), 28.2 (NC(O)CHCH2), 29.8 
(CH3), 41.4 (CH3C(O)CH2), 48.1 (NCH2), 50.2 (NC(O)CH), 83.2 (C(CH3)3), 127.0 (CH, Ph), 127.1 
(CH, Ph), 127.4 (2 x CH, Ph), 128.2 (2 x CH, Ph), 128.4 (2 x CH, Ph), 128.6 (2 x CH, Ph), 137.9 (C, 
Ph), 139.1 (C, Ph), 152.9 (NC(O)O), 176.4 (NC(O)), 208.2 (C(O)); IR (neat) νmax/cm-1 2978w, 
2934w, 1729s, 1716s, 1688m, 1367m, 1214m, 1142s; m/z (ES+) 418.2 ([M+Na]+, 100%); HRMS 
(ES+) 418.1988 [M+Na]+, C24H29NO4Na requires 418.1994. 
1-Benzyl-3-(4-methoxyphenyl)thiourea 6070 
Synthesised according to the literature procedure.71 p-Methoxyphenyl isothiocyanate (375 µL, 
2.71 mmol) was added to a solution of benzylamine (296 µL, 2.71 mmol) in CH2Cl2 (6.5 mL) at 
0 °C. The reaction mixture was then warmed to rt, stirred for 16 h and then concentrated 
under reduced pressure. Purification by flash column chromatography (5:2 petrol/EtOAc) 
afforded thiourea 60 as a white powder (681 mg, 92%). Rf 0.41 (1:1 petrol/EtOAc); m.p. 103-
105 °C (lit. 113-114 °C); 1H NMR (300 MHz, CDCl3): δ 3.79 (3H, s, OCH3), 4.85 (1H, s, CHH’Ph), 
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4.87 (1H, s, CHH’Ph), 6.08 (1H, br s, NH), 6.87-6.94 (2H, m, 2 x CH, PMP), 7.12-7.19 (2H, m, 2 x 
CH, PMP), 7.23-7.38 (5H, m, Ph), 7.89 (1H, br s, NH); 13C NMR (100 MHz, CDCl3): δ 49.3 
(NCH2Ph), 55.5 (OCH3), 115.3 (2 x CH, PMP), 127. 5 (2 x CH, PMP), 127.6 (CH, Ph), 127.8 (2 x 
CH, Ph), 128.7 (2 x CH, Ph), 128.8 (CNH, PMP) 137.4 (C, Ph), 159.0 (COCH3, PMP), 181.5 
(NHC(S)NH); IR (neat) νmax/cm-1 3384m, 3164m, 3014m, 1588m, 1542s, 1522s, 1504s, 1494s, 
1311m, 1237s, 1227s, 1025s, 968m.  
1-Benzyl-3-(4-methoxyphenyl)-2-methylguanidine 61 
Methyl iodide (25 µL, 0.400 mmol) was added to a solution of thiourea 60 (99 mg, 0.363 mmol) 
in acetone (2 mL) and the reaction mixture was heated under reflux for 2.5 h. The solvent was 
then evaporated, the residue was dissolved in MeOH (0.7 mL) and methylamine (2.0 M in THF, 
540 µL, 1.09 mmol) was added. The sealed tube was then heated to 100 °C for 17 h. The 
reaction mixture was cooled to rt, diluted with CH2Cl2 (30 mL) and washed with saturated 
aqueous NaHCO3 (40 mL). The aqueous layer was then extracted with CH2Cl2 (30 mL) and the 
combined organic layers were washed with brine (50 mL), dried with Na2SO4 and concentrated 
under reduced pressure. Purification of a 23 mg portion of the crude product by flash column 
chromatography (neutral alumina, 4:1 to 0:1 petrol/EtOAc) afforded guanidine 61 as a white 
powder (9 mg, 39%). Rf 0.28 (1:1 petrol/EtOAc); m.p. 141-143 °C; 1H NMR (300 MHz, CDCl3): δ 
1.26 (3H, s, NCH3), 3.77 (3H, s, OCH3), 4.38 (1H, s, NCHH’), 4.40 (1H, s, NCHH’), 5.21 (1H, br s, 
NH), 6.51 (1H, br s, NH), 6.79-6.86 (2H, m, 2 x CH, PMP), 7.13-7.20 (2H, m, 2 x CH, PMP), 7.21-
7.35 (5H, m, Ph); 13C NMR (100 MHz, CDCl3): δ 29.7 (NCH3), 44.2 (NCH2), 55.5 (OCH3), 114.6 (2 
x CH, PMP), 124.9 (2 x CH, PMP), 127.3 (CH, Ph), 127.4 (2 x CH, Ph), 128.6 (2 x CH, Ph), 130.7 
(CNH, PMP), 139.1 (C, Ph), 156.6 (COCH3, PMP), 157.1 (C=N); IR (neat) νmax/cm-1 3305br, 
2954w, 2922m, 2853w, 1630s, 1609s, 1562s, 1508s, 1455m, 1242s, 1033m; m/z (ES+) 270.2 
([M+H]+, 20%); HRMS (ES+) 270.1612 [M+H]+, C16H20N3O requires 270.1606. 
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9-Amino-(9-deoxy)-epi-quinine 6272  
Quinine 2 (3.27 g, 10.1 mmol) was added to a solution of triphenylphosphine (3.18 g, 12.1 
mmol) in THF (50 mL) at 0 °C. Diisopropyl azodicarboxylate (2.38 mL, 12.2 mmol) was added 
in one portion followed by a solution of diphenyl phosphoryl azide (2.61 mL, 12.1 mmol) in 
THF (20 mL). The reaction mixture was warmed to rt and stirred for 12 h, then warmed to 50 
°C and stirred for 2 h. A second quantity of triphenylphosphine (3.44 g, 13.1 mmol) was then 
added and heating was maintained for a further 2 h. The reaction mixture was then cooled to 
rt, H2O (1 mL) was added and stirring was continued for 18 h. The reaction mixture was 
concentrated under reduced pressure and the residue was dissolved in CH2Cl2 (300 mL) and 
10% HCl (300 mL). The aqueous layer was washed with CH2Cl2 (3 x 200 mL) and adjusted to pH 
10 with concentrated NH4OH. The aqueous layer was then extracted with CH2Cl2 (4 x 200 mL) 
and these combined organic layers were dried with Na2SO4 and concentrated under reduced 
pressure to afford amine 62 as an orange semi-solid (3.18 g, 98%). Product was used crude 
but a small portion was recrystallized as the HCl salt. 
Crude product (910 mg, 1.86 mmol) was dissolved in CH2Cl2 (100 mL) and extracted into 2 N 
HCl (100 mL). The aqueous phase was then washed with CH2Cl2 (2 x 100 mL) and concentrated 
under reduced pressure to give the 3HCl salt. This was recrystallized from MeOH and EtOAc 
and dried under reduced pressure. The product was basified with 1 N NaOH (100 mL) to 
achieve a pH of 10 and extracted with CH2Cl2 (4 x 100 mL). The combined organic layers were 
washed with brine, dried with Na2SO4 and concentrated under reduced pressure to afford the 
analytically pure amine 62 (507 mg, 56%). Rf 0.07 (3:1 EtOAc/MeOH); 1H NMR (400 MHz, 
CDCl3): δ 0.65-0.77 (1H, m, CHH7), 1.30-1.41 (1H, m, CHH7), 1.43-1.52 (2H, m, CH25), 1.52-1.57 
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(1H, m, CH4), 2.00-2.25 (3H, m, NH2 overlays CH3), 2.67-2.78 (2H, m, CHH6 and CHH2), 2.95-
3.07 (1H, m, CH8), 3.09-3.18 (1H, m, CHH6), 3.20 (1H, dd, J = 14.0, 10.0, CHH2), 3.88 (3H, s, 
OCH3), 4.53 (1H, br d, J = 9.0 Hz, CH9NH2), 4.86-4.98 (2H, m, CH=CH2), 5.73 (1H, ddd, J = 17.0, 
10.0, 7.5 Hz, CH=CH2), 7.31 (1H, dd, J = 9.0, 3.0 Hz, CH7’), 7.34-7.42 (1H, m, CH3’), 7.59 (1H, br 
s, CH5’), 7.96 (1H, d, J = 9.0 Hz, CH8’), 8.66 (1H, d, J = 4.5 Hz, CH2’); 13C NMR (100 MHz, CDCl3): 
δ 26.0 (C7H2), 27.5 (C4H), 28.2 (C5H2), 39.8 (C3H), 41.0 (C6H2), 52.5 (C9H), 55.5 (OCH3), 56.3 
(C2H2), 61.8 (C8H), 102.0 (C5’H), 114.3 (CH=CH2), 119.9 (C3’H), 121.2 (C7’H), 128.8 (C4a’), 131.7 
(C8’H), 141.8 (CH=CH2), 144.7 (C4’), 147.0 (C8a’), 147.8 (C2’H), 157.6 (C6’OMe); IR (neat) νmax/cm-
1 3366w, 2933m, 2862m, 1620s, 1589m, 1506s, 1473m, 1431m, 1228s, 1029s, 912s; [α]D +98 
° (c = 1.0, CHCl3, 20 °C), (lit.73 [α]D +80 ° (c = 1.1, CHCl3, 20 °C)). 
1-(4-Methoxyphenyl)-3-((S)-(6-methoxyquinolin-4-yl)((1S,2R,4S,5R)-5-
vinylquinuclidin-2-yl)methyl)thiourea 63 
Synthesised according to the literature procedure.71 p-Methoxyphenyl isothiocyanate (971 µL, 
7.03 mmol) was added to a solution of amino quinine 62 (2.27 g, 7.03 mmol) in CH2Cl2 (17.5 
mL) at 0 °C. The reaction mixture was then warmed to rt, stirred for 16 h and then 
concentrated under reduced pressure. Purification by flash column chromatography (97:3:0 
to 93:6:1 CH2Cl2/MeOH/NEt3) afforded thiourea 63 as a pale yellow powder (2.35 g, 68%). Rf 
0.38 (3:1 EtOAc/MeOH); m.p. 110-113 °C; 1H NMR (400 MHz, CDCl3): δ 0.92-1.00 (1H, m, 
CHH7), 1.28-1.39 (1H, m, CHH7), 1.55-1.74 (3H, m, CH4 and CH25), 2.22-2.32 (1H, m, CH3), 2.62-
2.74 (2H, m, CHH6 and CHH2), 3.13 (1H, dd, J = 13.5, 10.0 Hz, CHH2), 3.12-3.22 (1H, m, CH8), 
3.30-3.41 (1H, m, CHH6), 3.83 (3H, s, C6’OCH3), 3.95 (3H, s, C14OCH3), 4.90-4.98 (2H, m, 
CH=CH2), 5.64 (1H, ddd, J = 17.0, 10.0, 7.5 Hz, CH=CH2), 5.89 (1H, br s, CH9), 6.89 (2H, d, J = 9.0 
Hz, 2 x CH13 ), 7.13 (2H, d, J = 9.0 Hz, 2 x CH12), 7.16-7.23 (1H, m, C3’H), 7.36 (1H, dd, J = 9.0, 2.5 
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Hz, C7’H), 7.79 (1H, br s, CH5’), 7.98 (1H, d, J = 9.0 Hz, CH8’), 8.52 (1H, d, J = 4.0 Hz, CH2’). NH 
protons not observed; 13C NMR (100 MHz, CDCl3): δ 25.7 (C7H2), 27.2 (C5H2), 27.6 (C4H), 39.2 
(C3H), 41.4 (C6H2), 55.2 (C2H2), 55.5 (C6’OCH3), 55.7 (PhOCH3), 60.7 (C8H, overlays C9H), 102.4 
(C5’H), 114.6 (2 x C13H), 114.8 (CH=CH2), 119.8 (C3’H), 121.8 (C7’H), 127.3 (2 x C12H, overlays 
C8a’), 128.1 (C4a’), 130.0 (C11), 131.6 (C8’H), 140.7 (CH=CH2), 144.7 (C4’), 147.5 (C2’H), 157.8 
(C6’OMe), 158.3 (C14), 181.0 (C10=S); IR (neat) νmax/cm-1 3188w, 2935w, 1621w, 1506s, 1474m, 
1238s, 1227s, 1028m; m/z (ES+) 489.2 ([M+H]+, 100%); HRMS (ES+) 489.2329 [M+H]+, 
C28H33N4O2S requires 489.2324; [α]D −142 ° (c = 1.0, CHCl3, 20 °C). 
N-Cyclohexyl-1,3-dimethylimidazolidin-2-imine 6974 
Synthesised according to the literature procedure.75 Dicyclohexyl carbodiimide (240 mg, 1.16 
mmol) was added to a solution of dimethyl ethylenediamine 68 (150 µL, 1.37 mmol) in toluene 
(7 mL) in a sealed tube. The sealed tube was then heated to 115 °C for 64 h. The reaction 
mixture was then concentrated under reduced pressure. The residue was treated with 30% 
aqueous NaOH (100 mL) and extracted with Et2O (3 x 80 mL). The combined organic layers 
were dried with Na2SO4 and concentrated under reduced pressure. Purification by flash 
column chromatography (neutral alumina, EtOAc with 3-30% MeOH) afforded guanidine 69 
as a yellow oil (82 mg, 31%). Rf 0.05 (3:1 EtOAc/MeOH); 1H NMR (400 MHz, CDCl3): δ 1.03-1.32 
(6H, m, Cy), 1.62-1.70 (4H, m, Cy), 2.70 (6H, br s, 2 x NCH3), 3.06 (4H, s, NCH2CH2N), 3.31-3.41 
(1H, m, NCH); 13C NMR (100 MHz, CDCl3): δ 25.3 (3 x CH2, Cy), 25.9 (2 x CH2, Cy), 36.6 (2 x 
NCH3), 49.4 (br, 2 x NCH2), 54.2 (NCH), 155.7 (C=N); IR (neat) νmax/cm-1 2923m, 2849m, 1655s, 
1479w, 1447m, 1378m, 1260m, 1226m, 1029m, 950m; m/z (ES+) 196.2 ([M+H]+, 90%); HRMS 
(ES+) 196.1820 [M+H]+, C11H22N3 requires 196.1814. 
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1-((S)-(6-Methoxyquinolin-4-yl)((1S,2R,4S,5R)-5-vinylquinuclidin-2-
yl)methyl)guanidine 77 
Synthesised according to the literature procedure.76 Amine 62 (136 mg, 0.420 mmol) was 
added to a stirring solution of NEtiPr2 (73 µL, 0.420 mmol) and 1H-pyrazole-1-carboxamidine 
hydrochloride (62 mg, 0.420 mmol) in DMF (0.40 mL). The reaction mixture was stirred at rt 
for 23 h before Et2O (3 mL) was added to precipitate the product. The product was then 
filtered and washed with more Et2O (2 x 5 mL) before drying under reduced pressure to afford 
guanidine 77 as a white powder (136 mg, 88%). Rf 0.08 (1:1 EtOAc/MeOH); m.p. decomposed 
at 200 °C; 1H NMR (400 MHz, CD3OD): δ 0.97-1.08 (1H, m, CHH7), 1.29-1.42 (1H, m, CHH7), 
1.59-1.81 (3H, m, CH25 and CH4), 2.40 (1H, br s, CH3), 2.84-3.04 (2H, m, CHH6 and CHH2), 3.25-
3.52 (3H, m, CHH6, CH8 and CHH2), 4.04 (3H, s, OCH3), 4.95-5.10 (2H, m, CH=CH2), 5.36 (1H, br 
s, CH9NH), 5.81 (1H, ddd, J = 17.5, 10.5, 7.5 Hz, CH=CH2), 7.51 (1H, dd, J = 9.0, 2.5 Hz, CH7’), 
7.64-7.70 (2H, m, CH3’ and CH5’), 8.02 (1H, d, J = 9.0 Hz, CH8’), 8.73 (1H, d, J = 4.5 Hz, CH2’), NH 
protons not observed; 13C NMR (100 MHz, CD3OD): δ 26.5 (C7H2), 28.4 (C4H), 28.8 (C5H2), 40.6 
(C3H), 42.1 (C6H2), 56.2 (C2H2), 56.9 (OCH3), 60.0 (C9H overlays C8H), 103.3 (C5’H), 115.4 
(CH=CH2), 122.7 (C3’H), 123.8 (C7’H), 129.2 (C4a’), 132.2 (C8’H), 142.4 (CH=CH2), 144.4 (C4’), 
145.6 (C8a’), 148.6 (C2’H), 159.1 (C6’OMe), 160.3 (C=NH); IR (neat) νmax/cm-1 3130w (br), 2945w, 
1660m, 1637s, 1622m, 1509w, 1478w, 1230m, 1026m; m/z (ES+) 366.2 ([M+H]+, 100%), 183.6 
([M+2H]2+, 50%); HRMS (ES+) 366.2300 [M+H]+, C21H28N5O requires 366.2294; [α]D −44.4° (c = 
1.0, MeOH, 23 °C). 
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1,3-Dibenzylimidazolidine-2,4-dione 8077 
Synthesised according to the literature procedure.78 NaH (60% in mineral oil, 186 mg, 4.66 
mmol) was added to a solution of hydantoin 79 (222 mg, 2.22 mmol) in DMF (6 mL). After 15 
min at rt, benzyl bromide (554 µL, 4.66 mmol) as a solution in DMF (5 mL) was added dropwise 
over 10 min. The reaction mixture was stirred at rt for 18 h, poured into H2O (80 mL) and 
extracted with EtOAc (3 x 80 mL). The combined organic layers were washed with brine (150 
mL), dried with MgSO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (4:1:0 to 1:0:0 to 98:0:2 CH2Cl2/petrol/MeOH) afforded protected hydantoin 
80 as a pale yellow oil (298 mg, 48%). Rf 0.15 (1:1 petrol/Et2O); 1H NMR (300 MHz, CDCl3): δ 
3.65 (2H, s, CH2CO), 4.47 (2H, s, NCH2), 4.61 (2H, s, NCH2), 7.13-7.39 (10H, m, 2 x Ph); 13C NMR 
(100 MHz, CDCl3): δ 42.6 (CH2CO), 46.7 (NCH2), 49.1 (NCH2), 127.9 (CH, Ph), 128.1 (2 x CH, Ph), 
128.2 (CH, Ph), 128.6 (2 x CH, Ph), 128.7 (2 x CH, Ph), 129.0 (2 x CH, Ph), 135.3 (C, Ph), 136.0 
(C, Ph), 156.5 (NC(O)N), 169.5 (NC(O)CH2); IR (neat) νmax/cm-1 3032w, 2926w, 1768w, 1701s, 
1451m, 1336m, 1235m, 1137m. 
1,3-Di-(tert-butoxycarbonyl)hydantoin 8279 
Di-tert-butyl dicarbonate (1.82 mL, 7.92 mmol) and DMAP (10 mg, 0.079) were added slowly 
to a solution of hydantoin 79 (317 mg, 3.17 mmol) in THF (20 mL) at 0 °C. The reaction mixture 
was then stirred at rt for 18 h and concentrated under reduced pressure. The residue was 
treated with CH2Cl2 (400 mL) and washed with 2 N HCl (200 mL), saturated aqueous NaHCO3 
(200 mL) and brine (200 mL). The organic layer was then dried with MgSO4 and concentrated 
under reduced pressure. Purification by flash column chromatography (1:1 petrol/Et2O) 
afforded protected hydantoin 82 as a pale yellow powder (489 mg, 51%). Rf 0.69 (EtOAc); m.p. 
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138-139 °C (lit. 141-143 °C); 1H NMR (300 MHz, CDCl3): δ 1.56 (9H, s, C(CH3)3), 1.59 (9H, s, 
C(CH3)3), 4.24 (2H, s, CH2); 13C NMR (100 MHz, CDCl3): δ 27.7 (C(CH3)3), 27.9 (C(CH3)3), 48.2 
(NCH2), 85.1 (C(CH3)3), 86.8 (C(CH3)3), 145.0 (NC(O)O), 147.3 (NC(O)O), 148.2 (NC(O)N), 163.9 
(NC(O)CH2); IR (neat) νmax/cm-1 3285m, 3063w, 3032w, 1771w, 1718w, 1635s, 1547s, 1490m, 
1453m, 1364m, 1316m, 1259s, 1159m, 1027m.  
3-Benzylimidazolidine-2,4-dione 8780 
Benzyl bromide (4.26 mL, 35.9 mmol) was added to a suspension of hydantoin 79 (1.20 g, 12.0 
mmol) and K2CO3 (4.96 g, 35.9 mmol) in DMF (38 mL). The reaction mixture was then heated 
to 60 °C for 18 h and then H2O (300 mL) was added. The product was extracted with EtOAc (3 
x 200 mL) and the combined organic layers were washed with brine (300 mL), dried with 
Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (11:2 to 0:1 petrol/EtOAc) afforded mono-protected hydantoin 87 as a white 
solid (1.63 g, 72%). Rf 0.46 (EtOAc); m.p. 130-132 °C (lit. 132-133 °C); 1H NMR (300 MHz, CDCl3): 
δ 3.98 (2H, app d, J = 1.0 Hz, CH2NH), 4.68 (2H, s, NCH2), 6.41 (1H, br s, NH), 7.26-7.45 (5H, m, 
Ph); 13C NMR (100 MHz, CDCl3): δ 42.2 (CH2NH), 46.5 (NCH2), 128.0 (CH, Ph), 128.6 (2 x CH, 
Ph), 128.7 (2 x CH, Ph), 135.8 (C, Ph), 158.3 (HNC(O)), 171.0 (CH2C(O)); IR (neat) νmax/cm-1 
3222w, 3098w, 1768m, 1724s, 1706s, 1459s, 1450s, 1340m, 1141m. 
3-Benzyl-2-methoxy-3,5-dihydro-4H-imidazol-4-one 88 
 Synthesised according to the literature procedure.81 Hydantoin 87 (106 mg, 0.558 mmol) as a 
solution in CH2Cl2 (1.5 mL) was added to trimethyloxonium tetrafluoroborate (99 mg, 0.669 
mmol) in CH2Cl2 (1.5 mL). The reaction mixture was stirred at rt for 17 h. It was then diluted 
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with CH2Cl2 (20 mL), washed with ice cold saturated aqueous NaHCO3 (20 mL), dried with 
MgSO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (2:1 to 1:0 EtOAc/petrol) afforded the lactim ether 88 as white powder (64 
mg, 19%). Rf 0.26 (EtOAc); m.p. 60-63 °C; 1H NMR (300 MHz, CDCl3): δ 3.99 (3H, s, CH3), 4.10 
(2H, s, CH2C(O)), 4.62 (2H, s, NCH2) 7.26-7.38 (5H, m, Ph); 13C NMR (100 MHz, CDCl3): δ 43.1 
(NCH2), 55.5 (OCH3), 56.6 (CH2C(O)), 127.8 (CH, Ph), 128.0 (2 x CH, Ph), 128.6 (2 x CH, Ph), 
136.0 (C, Ph), 160.4 (NC=N), 178.8 (NC(O)); IR (neat) νmax/cm-1 2949w, 1732s, 1655s, 1462s, 
1454s, 1384s, 1355s, 1294m, 1234s, 1038s; m/z (ES+) 205.1 ([M+H]+, 100%); HRMS (ES+) 
205.0980 [M+H]+, C11H13N2O2 requires 205.0977. 
Thalidomide 9482 
Phthalic anhydride (2.60 g, 17.6 mmol) was added to L-glutamine (2.59 g, 17.7 mmol) in 
pyridine (13 mL) and stirred at 80 °C for 22 h then cooled to 5 °C. Thionyl chloride (1.32 mL, 
18.2 mmol) was added slowly over 5 min. The reaction mixture was then stirred at rt for 3 h. 
The pyridine was then removed under reduced pressure until the volume of the reaction 
mixture was reduced by 80%. A 4:1 mixture of water/ethanol (50 mL) was added and the 
mixture was cooled to 10 °C in an ice bath before concentrated HCl solution was added to 
achieve a pH of 7.0 ± 0.5. After stirring at rt for 4 h, the precipitate was filtered by suction 
filtration, washed with water (100 mL) and dried under reduced pressure to afford 
thalidomide 94 as a pale brown powder (1.08 g, 24%). Rf 0.26 (1:1 petrol/EtOAc); m.p. 221-
224 °C (recrystallised from ethanol, lit. 274-276 °C); 1H NMR (400 MHz, DMSO): δ 2.01-2.13 
(1H, m, C(O)CHH’), 2.50-2.65 (2H, m, C(O)CHH’CHH’), 2.84-2.96 (1H, m, C(O)CH2CHH’), 5.16 
(1H, dd, J = 13.0, 5.5 Hz, C(O)CH), 7.87-7.96 (4H, m, 4 x CH, Ar), 11.14 (1H, br s, NH); 13C NMR 
(100 MHz, DMSO): δ 22.0 (C(O)CHCH2), 30.9 (C(O)CH2), 49.0 (C(O)CH), 123.4 (2 x CH, Ar),  131.2 
(2 x C, Ar), 134.9 (2 x CH, Ar), 167.1 (C(O)NC(O)), 169.8 (CHC(O)NH), 172.7 (CH2C(O)NH); IR 
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(neat) νmax/cm-1  3200w (br), 3097w, 1771w, 1697s, 1469w, 1383m, 1360m, 1324m, 1256m, 
1196m, 1113m. 
tert-Butyl 3-(1,3-dioxoisoindolin-2-yl)-2,6-dioxopiperidine-1-carboxylate 97 
Di-tert-butyl dicarbonate (104 µL, 0.451 mmol) and DMAP (5 mg, 0.041 mmol) were added to 
thalidomide 94 (106 mg, 0.410 mmol) as a solution in 1,4-dioxane (1.2 mL). The reaction 
mixture was stirred at rt for 21 h and then diluted with Et2O (2 mL). The product was filtered, 
washed with Et2O (3 x 5 mL) and dried under reduced pressure to afford Boc protected 
thalidomide 97 as a pale brown solid (96 mg, 65%). Rf 0.41 (1:1 petrol/EtOAc); m.p. 
decomposed above 223 °C. 1H NMR (400 MHz, CDCl3): δ 1.56 (9H, s, C(CH3)3), 2.11-2.19 (1H, 
m, C(O)CHH’), 2.77-3.04 (3H, m, C(O)CHH’CH2), 5.05 (1H, dd, J = 13.0, 5.5 Hz, C(O)CH), 7.74-
7.81 (2H, m, 2 x CH, Ar), 7.86-7.93 (2H, m, 2 x CH, Ar); 13C NMR (100 MHz, CDCl3): δ 21.8 
(C(O)CHCH2), 27.4 (C(CH3)3), 31.6 (C(O)CH2), 49.5 (C(O)CH), 86.8 (C(CH3)3), 123.8 (2 x CH, Ar), 
131.7 (2 x C, Ar), 134.5 (2 x CH, Ar), 147.7 (NC(O)O), 166.1 (CHC(O)NH), 167.1 (C(O)NC(O)), 
168.6 (CH2C(O)NH); IR (neat) νmax/cm-1 3005w, 1784m, 1713s, 1694s, 1388m, 1248s, 1140s; 
m/z (ES+) 381.1 ([M+Na]+, 10%), 739.2 ([2M+Na]+, 100%); HRMS (ES+) 381.1067 [M+Na]+, 
C18H18N2O6Na requires 381.1063. 
tert-Butyl (2-(benzylamino)-2-oxo-1-phenylethyl)carbamate 10183 
Boc protected amino acid 100 was synthesised according to the literature procedure.84 
Phenylglycine 99 (1.21 g, 7.99 mmol) was suspended in 1 N NaOH (16 mL) and 1,4-dioxane (5 
mL) and cooled to 0 °C. Di-tert-butyl dicarbonate (2.02 mL, 8.79 mmol) in 1,4-dioxane (6 mL) 
was added to the reaction mixture and it was warmed to rt and stirred for 18 h. The reaction 
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mixture was then diluted with H2O (300 mL) and washed with petrol (3 x 200 mL). The aqueous 
layer was then carefully adjusted to pH 4 with citric acid and extracted with EtOAc (3 x 300 
mL). The combined organic layers were washed with H2O (400 mL) and brine (400 mL), dried 
with MgSO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (3:1 petrol/EtOAc) afforded Boc amine 100 (1.57 g, 78%). 
Amide 101 was synthesised according to the literature procedure.85 NEt3 (870 µL, 6.24 mmol) 
and ethyl chloroformate (597 µL, 6.24 mmol) were added slowly to a solution of Boc amine 
100 (1.43 g, 5.67 mmol) in CH2Cl2 (23 mL) at 0 °C. The reaction mixture was warmed to rt and 
after 1 h, benzylamine (743 µL, 6.80 mmol) was added. After a further 2 h, the reaction mixture 
was diluted with CH2Cl2 (300 mL) and washed with saturated aqueous NaHCO3 (200 mL) and 
brine (200 mL). The organic layer was dried with MgSO4, concentrated under reduced pressure 
and purified by flash column chromatography (2:1 petrol/EtOAc) to afford amide 101 as white 
powder (1.77 g, 92%). Rf 0.46 (1:1 petrol/EtOAc); m.p. 123-125 °C (lit. 118-119); 1H NMR (300 
MHz, CDCl3): δ 1.40 (9H, s, C(CH3)3), 4.42 (1H, s, CHH’), 4.44 (1H, s, CHH’), 5.21 (1H, br s, NH), 
5.86 (1H, br s, CHNH), 6.15 (1H, br s, NH), 7.09-7.43 (10H, m, 2 x Ph); 13C NMR (100 MHz, 
CDCl3): δ 28.3 (C(CH3)3), 43.6 (CH2), 58.6 (CHNH), 80.1 (C(CH3)3), 127.2 (3 x CH, Ph), 127.5 (2 x 
CH, Ph), 128.4 (CH, Ph), 128.6 (2 x CH, Ph), 129.0 (2 x CH, Ph), 137.7 (C, Ph), 138.4 (C, Ph), 155.2 
(C(O)O), 170.1 (C(O)NH); IR (neat) νmax/cm-1 3278m, 2982w, 1689m, 1651s, 1561m, 1518s, 
1495s, 1453m, 1364s, 1240s, 1156s, 1030m. 
N-Benzyl-2-(benzylamino)-2-phenylacetamide 103 
Amine 102 was synthesised according to the literature procedure.86 Trifluoroacetic acid (5.7 
mL) was added carefully to a solution of Boc amide 101 (1.68 g, 4.94 mmol) in CH2Cl2 (17 mL) 
at 0 °C and the reaction mixture was warmed to rt and stirred for 2 h. The solvent was the 
evaporated under reduced pressure and the residue was taken up in EtOAc (500 mL) which 
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was washed with saturated aqueous NaHCO3 (400 mL). The organic layer was then dried with 
Na2SO4 and concentrated under reduced pressure to afford amine 102 as a yellow oil (809 mg, 
68%).  
Amino amide 103 was synthesised according to the literature procedure.87 Benzaldehyde (346 
µL, 3.40 mmol) was added to a solution of amine 102 (779 mg, 3.24 mmol) in EtOH (29 mL) 
and stirred at rt for 2 h. The reaction mixture was then cooled to 0 °C, NaBH4 (270 mg, 7.10 
mmol) was added and stirring was continued at rt for 18 h. The reaction mixture was then 
carefully quenched with H2O (100 mL) and extracted with CH2Cl2 (3 x 200 mL). The combined 
organic layers were dried with Na2SO4 and concentrated under reduced pressure. Flash 
column chromatography (5:1 to 3:1 petrol/EtOAc, 2% NEt3) afforded amino amide 103 as 
colourless viscous oil (563 mg, 53%). Rf 0.39 (1:1 petrol/EtOAc); 1H NMR (300 MHz, CDCl3): δ 
2.05 (1H, br s, CHNH), 3.78 (2H, s, CHNHCH2), 4.31 (1H, s, CHNH), 4.46 (1H, s, C(O)NHCHH’), 
4.48 (1H, s, C(O)NHCHH’), 7.20-7.54 (15H, m, 3 x Ph), C(O)NH proton not observed; 13C NMR 
(100 MHz, CDCl3): δ 43.2 (C(O)NHCH2), 52.5 (NHCH2), 67.0 (NHCH), 127.1 (CH, Ph), 127.2 (2 x 
CH, Ph), 127.3 (CH, Ph), 127.4 (CH, Ph), 127.6 (2 x CH, Ph), 128.1 (2 x CH, Ph), 128.5 (2 x CH, 
Ph), 128.6 (2 x CH, Ph), 128.8 (2 x CH, Ph), 138.3 (C, Ph), 139.1 (2 x C, Ph), 171.9 (C(O)NH); IR 
(neat) νmax/cm-1 3305w (br), 3029w, 1653s, 1515m, 1495m, 1453m, 1265w, 1028w; m/z (ES+) 
331.2 ([M+H]+, 60%); HRMS (ES+) 331.1800 [M+H]+, C22H23N2O requires 331.1810. 
1,4-Dibenzyl-6-phenylpiperazine-2,3,5-trione 104 
A solution of amino amide 103 (46 mg, 0.139 mmol) in THF (0.4 mL) was added to a suspension 
of oxalyl benzotriazole (47 mg, 0.160 mmol) in THF (1.4 mL) in a microwave vial. The vial was 
then heated at 150 °C with stirring for 1 h in the microwave. The reaction mixture was 
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concentrated under reduced pressure and then purified by flash column chromatography (4:1 
petrol/EtOAc) to afford TKP 104 as a white powder (20 mg, 38%).  
NEt3 (15 µL, 0.109 mmol) was added to a solution of TKP 12b (32 mg, 0.104 mmol) and 
diphenyliodonium triflate (47 mg, 0.109 mmol) in CH2Cl2 (0.5 mL) at 0 °C. The reaction mixture 
was warmed to rt and after 19 h the reaction mixture was concentrated under reduced 
pressure. Purification by flash column chromatography (CH2Cl2) afforded TKP 104 as a white 
powder (19 mg, 48%).  
Rf 0.52 (1:1 petrol/EtOAc); 1H NMR (300 MHz, CDCl3): δ 3.59 (1H, d, J = 14.0 Hz, CHNCHH’), 
4.85 (1H, d, J = 14.0 Hz, C(O)NCHH’), 5.04 (1H, d, J = 14.0 Hz, C(O)NCHH’), 5.12 (1H, s, CHPh), 
5.54 (1H, d, J = 14.0 Hz, CHNCHH’), 7.13-7.48 (15H, m, 3 x Ph); 13C NMR (100 MHz, CDCl3): δ 
44.5 (C(O)NCH2), 47.8 (CHNCH2), 63.6 (CHPh), 126.8 (2 x CH, Ph), 128.1 (CH, Ph), 128.5 (2 x CH, 
Ph), 128.7 (CH, Ph), 129.0 (2 x CH, Ph), 129.1 (4 x CH, Ph), 129.7 (2 x CH, Ph), 129.8 (CH, Ph), 
133.8 (C, Ph), 133.9 (C, Ph), 134.9 (C, Ph), 152.9 (CHNC(O)), 156.3 (CHNC(O)C(O)), 166.6 
(CHC(O)); IR (neat) νmax/cm-1 3033w, 1748w, 1691s, 1673s, 1493w, 1451m, 1437m, 1386m, 
1370m, 1254m, 1188m; m/z (ES+) 385.2 ([M+H]+, 100%), 769.3 ([2M+H]+, 30%); HRMS (ES+) 
385.1560 [M+H]+, C24H21N2O3 requires 385.1552. 
Diphenyliodonium triflate 10888 
Synthesised according to the literature procedure.56 Iodobenzene (173 µL, 1.55 mmol) and 
benzene (155 µL, 1.75 mmol) were added to a solution of mCPBA (77% purity, 392 mg, 1.75 
mmol) in CH2Cl2 (6 mL). The solution was cooled to 0 °C and triflic acid (412 µL, 4.65 mmol) 
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was added dropwise over 5 min to give a suspension. After 10 min the reaction mixture was 
concentrated under reduced pressure and Et2O (6 mL) was added. After a further 10 min of 
stirring the flask was put in the freezer at −20 °C for 30 min. The precipitate was filtered, 
washed with cold Et2O (2 x 5 mL) and dried under reduced pressure to afford iodonium salt 
108 as pale orange crystals (647 mg, 97%). M.p. 158-159 °C (recrystallised from CH2Cl2/Et2O, 
lit. 172-174 °C); 1H NMR (300 MHz, CDCl3): δ 7.53 (4H, t, J = 7.5 Hz, 4 x CH, Ph), 7.67 (2H, t, J = 
7.5 Hz, 2 x CH, Ph), 8.25 (4H, d, J = 7.5 Hz, 4 x CH, Ph); 13C NMR (100 MHz, CDCl3): δ 116.5 (2 x 
C, Ph), 131.8 (4 x CH, Ph), 132.1 (2 x CH, Ph), 135.2 (4 x CH, Ph); IR (neat) νmax/cm-1 1472w, 
1444w, 1268s, 1243s, 1220s, 1168s, 1024m, 987m. 
1,4-Dibenzyl-6-(3-oxobutyl)-6-phenylpiperazine-2,3,5-trione 109 
Methyl vinyl ketone (11 µL, 0.130 mmol) was added to a solution of TKP 104 (20 mg, 0.052 
mmol) in CH2Cl2 (0.3 mL) at rt. Modified quinine catalyst 55 (4 mg, 9.4 µmol) was then added 
to the reaction mixture which was stirred at rt for 6 h. The solvent was removed under reduced 
pressure and flash column chromatography (5.5:1 to 4:1 petrol/EtOAc) afforded Michael 
adduct 109 as a white powder (18 mg, 75%). HPLC analysis was used to determine the er (see 
Table 8 for er values) (Daicel Chiralpak AD column, [9:1 hexane/IPA], retention times: 17.0 and 
25.3 min). Rf 0.39 (1:1 petrol/EtOAc); m.p. 121-123 °C;  1H NMR (400 MHz, CDCl3): δ 1.61 (3H, 
s, CH3), 1.76-1.83 (2H, m, C(O)CH2), 2.37-2.46 (1H, m, C(O)CH2CHH’), 2.95-3.04 (1H, m, 
C(O)CH2CHH’), 3.65 (1H, d, J = 15.0 Hz, PhCNCHH’), 4.94 (1H, d, J = 13.5 Hz, (C(O)NCHH’), 5.10 
(1H, d, J = 13.5 Hz, C(O)NCHH’), 5.23 (1H, d, J = 15.0 Hz, PhCNCHH’), 7.20-7.44 (15H, m, 3 x Ph); 
13C NMR (100 MHz, CDCl3): δ 29.3 (CH3), 30.0 (C(O)CH2CH2), 37.0 (C(O)CH2), 44.6 (C(O)NCH2), 
48.8 (PhCNCH2), 72.7 (CPh), 126.2 (2 x CH, Ph), 128.1 (CH, Ph), 128.2 (CH, Ph), 128.6 (2 x CH, 
Ph), 128.8 (2 x CH, Ph), 129.1 (4 x CH, Ph), 129.5 (CH, Ph), 129.6 (2 x CH, Ph), 135.0 (C, Ph), 
136.5 (C, Ph), 137.8 (C, Ph), 155.0 (PhCNC(O)C(O)), 155.7 (PhCNC(O), 169.0 (PhCC(O)), 205.0 
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(CH3C(O)); IR (neat) νmax/cm-1 3064w, 2852w, 1744w, 1713w, 1681s, 1495w, 1420m, 1359m, 
1266m, 1231m, 1144m, 1030w; m/z (ES+)  477.2 ([M+Na]+, 100%); HRMS (ES+) 477.1788 
[M+Na]+, C28H26N2O4Na requires 477.1790. 
tert-Butyl (2-((4-methoxybenzyl)amino)-2-oxo-1-phenylethyl)carbamate 110 
Synthesised according to the literature procedure.85 NEt3 (4.65 mL, 33.3 mmol) and isobutyl 
chloroformate (4.34 mL, 33.3 mmol) were added slowly to protected phenylglycine 100 (7.61 
g, 30.3 mmol) in CH2Cl2 (121 mL) at 0 °C. After stirring for 1 h, p-methoxybenzylamine (4.75 
mL, 16.3 mmol) was added and the reaction mixture was stirred for a further 2 h. CH2Cl2 (200 
mL) was added and the organic layer was washed with saturated aqueous NaHCO3 (200 mL) 
and brine (200 mL). The organic later was then dried with Na2SO4 and concentrated under 
reduced pressure. Purification by flash column chromatography (2:1 to 3:5 petrol/EtOAc) 
afforded amide 110 as a pale yellow solid (6.92 g, 62%). Rf 0.50 (1:1 petrol/EtOAc); m.p. 121-
122 °C; 1H NMR (300 MHz, CDCl3): δ 1.36 (9H, s, C(CH3)3), 3.76 (3H, s, OCH3), 4.29 (1H, s, 
NHCHH’), 4.31 (1H, s, NHCHH’), 5.31 (1H, br s, PhCH), 5.97 (1H, br s, NH), 6.62 (1H, br s, NH), 
6.76 (2H, d, J = 8.5 Hz, 2 x CH, PMP), 7.00 (2H, d, J = 8.5 Hz, 2 x CH, PMP), 7.27-7.43 (5H, m, 5 
x CH, Ph); 13C NMR (100 MHz, CDCl3): δ 28.2 (C(CH3)3), 43.0 (CH2), 55.2 (OCH3), 58.3 (CHPh), 
80.0 (C(CH3)3), 113.9 (2 x CH, PMP), 127.1 (2 x CH, Ph), 128.2 (CH, Ph), 128.7 (2 x CH, PMP), 
128.8 (2 x CH, Ph), 129.8 (CCH2, PMP), 138.5 (CCH, Ph), 155.2 (NHC(O)O), 158.8 (COCH3, PMP), 
170.1 (NHC(O)); IR (neat) νmax/cm-1 3341m, 3306m, 1672s, 1652s, 1559m, 1512s, 1498m, 
1365m, 1355m, 1247s, 1157s, 1034s; m/z (ES+) 393.2 ([M+Na]+, 100%); HRMS (ES+) 393.1783 
[M+Na]+, C21H26N2O4Na requires 393.1790. 
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2-Amino-N-(4-methoxybenzyl)-2-phenylacetamide 111 
Synthesised according to the literature procedure.86 Trifluoroacetic acid (21.3 mL) was added 
carefully to a solution of Boc amide 110 (6.85 g, 18.5 mmol) in CH2Cl2 (65 mL) at 0 °C and the 
reaction mixture was warmed to rt and stirred for 2 h. The solvent was then evaporated under 
reduced pressure and the residue was taken up in EtOAc (500 mL) which was washed with 
saturated aqueous NaHCO3 (400 mL). The organic layer was then dried with Na2SO4 and 
concentrated under reduced pressure to afford amine 111 as a yellow oil (4.54 g, 92%). Rf 0.47 
(EtOAc); m.p. 64-67 °C; 1H NMR (300 MHz, CDCl3): δ 1.97 (2H, br s, NH2), 3.80 (3H, s, OCH3), 
4.37 (1H, s, NHCHH’), 4.39 (1H, s, NHCHH’), 4.57 (1H, s, CHPh), 6.85 (2H, d, J = 7.0 Hz, 2 x CH, 
PMP), 7.16 (2H, d, J = 7.0 Hz, 2 x CH, PMP), 7.27-7.45 (5H, m, Ph). C(O)NH proton not observed; 
13C NMR (100 MHz, CDCl3): δ 42.8 (CH2), 55.3 (OCH3), 59.8 (CHPh), 114.0 (2 x CH, PMP), 126.9 
(2 x CH, Ph), 128.0 (CH, Ph), 128.8 (2 x CH, Ph), 129.0 (2 x CH, PMP), 130.4 (CCH2, PMP), 140.9 
(C, Ph), 158.9 (COCH3, PMP), 172.7 (NHC(O)); IR (neat) νmax/cm-1 3257w (br), 2936w, 1631m, 
1612m, 1511s, 1454m, 1303m, 1245s, 1176m, 1026s; m/z (ES+) 271.1 ([M+H]+, 100%); HRMS 
(ES+) 271.1444 [M+H]+, C16H19N2O2 requires 271.1447. 
N-(4-Methoxybenzyl)-2-((4-methoxybenzyl)amino)-2-phenylacetamide 112 
Synthesised according to the literature procedure.87 Anisaldehyde (569 µL, 4.67 mmol) was 
added to a solution of amine 111 (1.20 g, 4.45 mmol) in EtOH (40 mL) and stirred at rt for 21 
h. The reaction mixture was then cooled to 0 °C, NaBH4 (370 mg, 9.79 mmol) was added and 
stirring was continued at rt for 23 h. The reaction mixture was then carefully quenched with 
H2O (100 mL) and extracted with CH2Cl2 (3 x 200 mL). The combined organic layers were dried 
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with Na2SO4 and concentrated under reduced pressure. Flash column chromatography (4:1 to 
2:1 petrol/EtOAc, 2% NEt3) afforded amino amide 112 as yellow oil (1.09 g, 63%). Rf 0.21 (1:1 
petrol/EtOAc); 1H NMR (300 MHz, CDCl3): δ 3.70 (2H, s, CHNHCH2), 3.80 (6H, s, 2 x OCH3), 4.31 
(1H, s, CHPh), 4.38 (1H, s, C(O)NHCHH’), 4.40 (1H, s, C(O)NHCHH’), 6.81-6.89 (4H, m, 4 x CH, 
PMP), 7.12-7.21 (4H, m, 4 x CH, PMP), 7.28-7.41 (5H, m, Ph); 13C NMR (100 MHz, CDCl3): δ 42.6 
(C(O)NHCH2), 51.8 (NHCH2), 55.2 (2 x OCH3, PMP), 66.8 (CHPh), 113.9 (2 x CH, PMP), 114.0 (2 
x CH, PMP), 127.3 (2 x CH, Ph), 128.1 (CH, Ph), 128.8 (2 x CH, PMP), 129.0 (2 x CH, PMP), 129.4 
(2 x CH, Ph), 130.4 (CCH2, PMP), 131.2 (CCH2, PMP), 139.2 (C, Ph), 158.8 (COCH3, PMP), 158.9 
(COCH3, PMP), 171.8 (NHC(O)); IR (neat) νmax/cm-1 3308w (br), 2934w, 2835w, 1654m, 1611m, 
1511s, 1454m, 1243s, 1175m, 1031m; m/z (ES+) 391.2 ([M+H]+, 100%); HRMS (ES+) 391.2030 
[M+H]+, C24H27N2O3 requires 391.2022. 
1,4-Bis(4-methoxybenzyl)-6-phenylpiperazine-2,3,5-trione 113 
A solution of amino amide 112 (52 mg, 0.134 mmol) in THF (0.4 mL) was added to a suspension 
of oxalyl benzotriazole (45 mg, 0.154 mmol) in THF (1.3 mL) in a microwave vial. The vial was 
then heated at 150 °C with stirring for 1 h in the microwave. The reaction mixture was 
concentrated under reduced pressure and then purified by flash column chromatography 
(100:0 to 95:5 CH2Cl2/Et2O) to afford TKP 113 as a white solid (17 mg, 28%). Rf 0.39 (1:1 
petrol/EtOAc); m.p.  150-152 °C; 1H NMR (300 MHz, CDCl3): δ 3.52 (1H, d, J = 14.5 Hz, 
CHNCHH’), 3.76 (3H, s, OCH3), 3.81 (3H, s, OCH3), 4.78 (1H, d, J = 13.5 Hz, C(O)NCHH’), 4.98 
(1H, d, J = 13.5 Hz, C(O)NCHH’), 5.10 (1H, s, CHPh), 5.47 (1H, d, J = 14.5 Hz, CHNCHH’), 6.74 
(2H, d, J = 9.0 Hz, 2 x CH, PMP), 6.85 (2H, d, J = 9.0 Hz, 2 x CH, PMP), 7.10 (2H, d, J = 9.0 Hz, 2 
x CH, PMP), 7.19-7.28 (4H, m, 2 x CH, PMP and 2 x CH, Ph), 7.37-7.47 (3H, m, 3 x CH, Ph); 13C 
NMR (100 MHz, CDCl3): δ 44.0 (C(O)NCH2), 47.2 (CHNCH2), 55.2 (OCH3),  55.3 (OCH3), 63.3 
(CHPh), 113.8 (2 x CH, PMP), 114.4 (2 x CH, PMP), 125.7 (CCH2, PMP), 126.8 (2 x CH, Ph), 127.2 
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(CCH2, PMP), 129.6 (2 x CH, PMP), 129.8 (2 x CH, PMP), 130.6 (CH, Ph), 130.7 (2 x CH, Ph), 134.0 
(C, Ph), 152.8 (CHNC(O)), 156.3 (CHNC(O)C(O)), 159.3 (COCH3, PMP), 159.8 (COCH3, PMP), 
166.7 (CHC(O)); IR (neat) νmax/cm-1 2959w, 2835w, 1750w, 1691s, 1673s, 1612m, 1513s, 
1432m, 1305m, 1238s, 1210m, 1190m, 1173m, 1028m; m/z (ES+) 467.2 ([M+Na]+, 100%); 
HRMS (ES+) 467.1599 [M+Na]+, C26H24N2O5Na requires 467.1583. 
1,4-Bis(4-methoxybenzyl)-6-(3-oxobutyl)-6-phenylpiperazine-2,3,5-trione 117 
Methyl vinyl ketone (13 µL, 0.155 mmol) was added to a solution of TKP 113 (28 mg, 0.062 
mmol) in CH2Cl2 (0.4 mL) at rt. Modified quinine catalyst 58 (5 mg, 12 µmol) was then added 
to the reaction mixture and stirred at rt for 72 h. Solvent was removed under reduced pressure 
and flash column chromatography (4:1 to 2:1 petrol/EtOAc) afforded Michael adduct 117 as a 
white solid (32 mg, quant). HPLC analysis was used to determine the er (see Table 9 for er 
values) (Daicel Chiralpak OD column, [4:1 hexane/IPA], retention times: 21.7 and 30.1 min). Rf 
0.47 (1:1 petrol/EtOAc); m.p. 145-147 °C; 1H NMR (300 MHz, CDCl3): δ 1.74 (3H, s, C(O)CH3), 
1.82-1.92 (2H, m, C(O)CH2), 2.46-2.59 (1H, m, C(O)CH2CHH’), 3.00-3.15 (1H, m, C(O)CH2CHH’), 
3.68 (1H, d, J = 14.5 Hz, PhCNCHH’), 3.82 (3H, s, OCH3), 3.83 (3H, s, OCH3), 4.95 (1H, d, J = 13.5 
Hz, C(O)NCHH’), 5.12 (1H, d, J = 13.5 Hz, C(O)NCHH’), 5.19 (1H, d, J = 14.5 Hz, PhCNCHH’), 6.76-
6.87 (4H, m, 4 x CH, PMP), 7.25-7.36 (4H, m, 4 x CH, PMP), 7.38-7.52 (5H, m, Ph); 13C NMR (100 
MHz, CDCl3): δ 29.3 (CH3), 30.1 (C(O)CH2CH2), 37.0 (C(O)CH2), 44.1 (C(O)NCH2), 48.2 
(PhCNCH2), 55.2 (OCH3),  55.3 (OCH3), 72.5 (CPh), 113.8 (2 x CH, PMP), 114.0 (2 x CH, PMP), 
126.2 (2 x CH, Ph), 127.2 (CCH2, PMP), 128.5 (CCH2, PMP), 129.4 (CH, Ph), 129.5 (2 x CH, Ph), 
130.6 (2 x CH, PMP), 130.7 (2 x CH, PMP), 137.9 (C, Ph), 154.9 (PhCNC(O)), 155.8 
(PhCNC(O)C(O)), 159.3 (COCH3, PMP), 159.4 (COCH3, PMP), 169.1 (PhCC(O)), 205.2 (CH3C(O)); 
IR (neat) νmax/cm-1 2958w, 1717w, 1681s, 1611w, 1512s, 1364m, 1247s, 1178m, 1031m; m/z 
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(ES+) 537.2 ([M+Na]+, 100%); HRMS (ES+) 537.2005 [M+Na]+, C30H30N3O6Na requires 537.2002; 
[α]D −15.1° (c = 1.0, CHCl3, 23 °C). 
1,4-Bis(4-methoxybenzyl)-6-(3-oxo-3-phenylpropyl)-6-phenylpiperazine-2,3,5-trione 
118 
Phenyl vinyl ketone (13 µL, 0.101 mmol) was added to a solution of TKP 113 (18 mg, 0.040 
mmol) in CH2Cl2 (0.24 mL) at rt. Modified quinine catalyst 58 (3 mg, 8 µmol) was then added 
to the reaction mixture and stirred at rt for 21 h. Solvent was removed under reduced pressure 
and flash column chromatography (7:2 to 2:1 petrol/EtOAc) afforded Michael adduct 118 as a 
white powder (21 mg, 91%). HPLC analysis was used to determine the er (see Table 9 for er 
values) (Daicel Chiralpak OD column, [4:1 hexane/IPA], retention times: 18.2 and 25.3 min). Rf 
0.42 (1:1 petrol/EtOAc); m.p. 174-175 °C; 1H NMR (300 MHz, CDCl3): δ 2.22-2.37 (2H, m, 
C(O)CH2), 2.55-2.75 (1H, m, C(O)CH2CHH’), 3.09-3.28 (1H, m, C(O)CH2CHH’), 3.44 (3H, s, OCH3), 
3.64 (1H, d, J = 14.5 Hz, PhCNCHH’), 3.67 (3H, s, OCH3), 4.91 (1H, d, J = 13.5 Hz, C(O)NCHH’), 
5.07 (1H, d, J = 13.5 Hz, C(O)NCHH’), 5.18 (1H, d, J = 14.5 Hz, PhCNCHH’), 6.47-6.55 (2H, m, 2 
x CH, PMP), 6.69-6.78 (2H, m, 2 x CH, PMP), 7.13-7.21 (2H, m, 2 x CH, PMP), 7.28-7.55 (12H, 
m, 2 x Ph, 2 x CH, PMP); 13C NMR (100 MHz, CDCl3): δ 30.5 (C(O)CH2CH2), 32.2 (C(O)CH2), 44.0 
(C(O)NCH2), 48.3 (PhCNCH2), 54.9 (OCH3), 55.1 (OCH3),  72.6 (CPh), 113.9 (2 x CH, PMP), 113.9 
(2 x CH, PMP), 126.3 (2 x CH, Ph), 127.4 (CCH2, PMP), 127.5 (2 x CH, Ph), 128.3 (2 x CH, Ph), 
128.3 (CCH2, PMP), 129.4 (CH, Ph), 129.5 (2 x CH, Ph), 130.3 (2 x CH, PMP), 130.8 (2 x CH, PMP), 
133.1 (CH, Ph), 135.9 (C, Ph), 138.0 (C, Ph), 155.0 (PhCNC(O)), 155.8 (PhCNC(O)C(O)), 159.0 
(COCH3, PMP), 159.4 (COCH3, PMP), 169.2 (PhCC(O)), 196.8 (C(O)Ph); IR (neat) νmax/cm-1 
2958w, 1678s, 1610m, 1512s, 1364m, 1302m, 1246s, 1177m; m/z (ES+) 599.2 ([M+Na]+,  
100%); HRMS (ES+) 599.2164 [M+Na]+, C35H32N2O6Na requires 599.2158; [α]D −3.2° (c = 1.0, 
CHCl3, 23 °C). 
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6-(3-Cyclohexyl-3-oxopropyl)-1,4-bis(4-methoxybenzyl)-6-phenylpiperazine-2,3,5-
trione 119 
Cyclohexyl vinyl ketone (18 µL, 0.118 mmol) was added to a solution of TKP 113 (21 mg, 0.047 
mmol) in CH2Cl2 (0.28 mL) at rt. Modified quinine catalyst 58 (4 mg, 9 µmol) was then added 
to the reaction mixture and stirred at rt for 45 h. Solvent was removed under reduced pressure 
and flash column chromatography (3:1 petrol/EtOAc) afforded Michael adduct 119 as a 
colourless solid (26 mg, 96%). HPLC analysis was used to determine the er (see Table 9 for er 
values) (Daicel Chiralpak OD column, [9:1 hexane/IPA], retention times: 28.4 and 37.7 min). Rf 
0.42 (1% MeOH in CH2Cl2); m.p. 64-67 °C; 1H NMR (300 MHz, CDCl3): δ 0.80-1.45 (6H, m, 3 x 
CH2, Cy), 1.50-1.77 (7H, m, 2 x CH2, CH, Cy and C(O)CH2), 2.35-2.51 (1H, m, C(O)CH2CHH’), 2.87-
3.03 (1H, m, C(O)CH2CHH’), 3.55 (1H, d, J = 14.5 Hz, PhCNCHH’), 3.72 (3H, s, OCH3), 3.75 (3H, 
s, OCH3), 4.87 (1H, d, J = 13.0 Hz, C(O)NCHH’), 5.03-5.15 (2H, m, C(O)NCHH’ and PhCNCHH’), 
6.66-6.79 (4H, m, 4 x CH, PMP),  7.18-7.48 (9H, m, 4 x CH, PMP and 5 x CH, Ph); 13C NMR (100 
MHz, CDCl3): δ 25.3 (CH2, Cy), 25.5 (CH2, Cy), 25.6 (CH2, Cy), 28.0 (CH2, Cy), 28.4 (CH2, Cy), 30.3 
(C(O)CH2CH2), 33.9 (C(O)CH2), 44.0 (C(O)NCH2), 48.3 (PhCNCH2), 50.4 (C(O)CH), 55.1 (2 x OCH3), 
72.6 (CPh), 113.8 (2 x CH, PMP), 113.9 (2 x CH, PMP), 126.4 (2 x CH, Ph), 127.3 (CCH2, PMP), 
128.6 (CCH2, PMP), 129.4 (CH, Ph), 129.5 (2 x CH, Ph), 130.6 (2 x CH, PMP), 130.8 (2 x CH, PMP), 
138.1 (C, Ph), 154.8 (PhCNC(O)), 155.8 (PhCNC(O)C(O)), 159.2 (COCH3, PMP), 159.4 (COCH3, 
PMP), 169.2 (PhCC(O)), 210.5 (C(O)Cy); IR (neat) νmax/cm-1 2930m, 1681s, 1512s, 1365m, 
1302m, 1246s, 1178m, 1032m; m/z (ES+) 605.3 ([M+Na]+, 100%); HRMS (ES+) 605.2625 
[M+Na]+, C35H38N2O6Na requires 605.2628; [α]D −4.1° (c = 1.0, CHCl3, 23 °C). 
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1,4-Bis(4-methoxybenzyl)-6-(3-oxopentyl)-6-phenylpiperazine-2,3,5-trione 115 
Ethyl vinyl ketone (11 µL, 0.112 mmol) was added to a solution of TKP 113 (20 mg, 0.045 mmol) 
in CH2Cl2 (0.27 mL) at rt. Modified quinine catalyst 58 (4 mg, 9 µmol) was then added to the 
reaction mixture and stirred at rt for 20 h. Solvent was removed under reduced pressure and 
flash column chromatography (7:2 petrol/EtOAc) afforded Michael adduct 115 as a colourless 
solid (26 mg, 96%). HPLC analysis was used to determine the er (see Table 9 for er values) 
(Daicel Chiralpak OD column, [9:1 hexane/IPA], retention times: 28.4 and 37.7 min). Rf 0.41 
(1:1 petrol/EtOAc); m.p. 120-122 °C; 1H NMR (300 MHz, CDCl3): δ 0.79 (3H, t, J = 7.5 Hz, CH3), 
1.65-1.99 (4H, m, CH2C(O)CH2), 2.39-2.53 (1H, m, C(O)CH2CHH’), 2.93-3.09 (1H, m, 
C(O)CH2CHH’), 3.60 (1H, d, J = 14.5 Hz, PhCNCHH’), 3.73 (3H, s, OCH3), 3.75 (3H, s, OCH3), 4.87 
(1H, d, J = 13.5 Hz, C(O)NCHH’), 5.03 (1H, d, J = 13.5 Hz, C(O)NCHH’), 5.12 (1H, d, J = 14.5 Hz, 
C(O)NCHH’), 6.67-6.78 (4H, m, 4 x CH, PMP),  7.17-7.27 (4H, m, 4 x CH, PMP), 7.30-7.45 (5H, 
m, Ph); 13C NMR (100 MHz, CDCl3): δ 7.5 (CH3), 30.1 (C(O)CH2CH2), 35.4 (C(O)CH2), 35.6 
(C(O)CH2), 44.1 (C(O)NCH2), 48.2 (PhCNCH2), 55.2 (2 x OCH3), 72.5 (CPh), 113.8 (2 x CH, PMP), 
113.9 (2 x CH, PMP), 126.2 (2 x CH, Ph), 127.3 (CCH2, PMP), 128.5 (CCH2, PMP), 129.4 (CH, Ph), 
129.5 (2 x CH, Ph), 130.6 (2 x CH, PMP), 130.7 (2 x CH, PMP), 138.0 (C, Ph), 154.9 (PhCNC(O)), 
155.8 (PhCNC(O)C(O)), 159.2 (COCH3, PMP), 159.4 (COCH3, PMP), 169.1 (PhCC(O)), 208.0 
(C(O)CH2CH3); IR (neat) νmax/cm-1 1715w, 1682s, 1513s, 1365m, 1303m, 1247s, 1178m, 
1032m; m/z (ES+) 551.2 ([M+H]+,  100%); HRMS (ES+) 551.5156 [M+H]+, C31H32N2O6Na requires 
551.2158; [α]D −12.0° (c = 1.0, CHCl3, 23 °C). 
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3-(1,4-Bis(4-methoxybenzyl)-3,5,6-trioxo-2-phenylpiperazin-2-yl)propanal 120 
Acrolein (15 µL, 0.231 mmol) was added to a solution of TKP 113 (21 mg, 0.046 mmol) in CH2Cl2 
(0.5 mL) at rt. Modified quinine catalyst 58 (4 mg, 9 µmol) was then added to the reaction 
mixture and stirred at rt for 72 h. Solvent was removed under reduced pressure and flash 
column chromatography (3:1 petrol/EtOAc) afforded Michael adduct 120 as a colourless solid 
(10 mg, 43%). Rf 0.39 (1:1 petrol/EtOAc); m.p. not obtainable; 1H NMR (300 MHz, CDCl3): δ 
1.80-1.93 (2H, m, C(O)CH2), 2.44-2.56 (1H, m, C(O)CH2CHH’), 3.01-3.14 (1H, m, C(O)CH2CHH’), 
3.59 (1H, d, J = 14.5 Hz, PhCNCHH’), 3.74 (3H, s, OCH3), 3.76 (3H, s, OCH3), 4.87 (1H, d, J = 13.0 
Hz, C(O)NCHH’), 5.01 (1H, d, J = 13.0 Hz, C(O)NCHH’), 5.18 (1H, d, J = 14.5 Hz, PhCNCHH’), 6.69-
6.79 (4H, m, 4 x CH, PMP), 7.18-7.29 (4H, m, 4 x CH, PMP), 7.30-7.46 (5H, m, Ph), 9.17 (1H, s, 
CHO); 13C NMR (100 MHz, CDCl3): δ 28.4 (C(O)CH2CH2), 38.0 (C(O)CH2), 44.2 (C(O)NCH2), 48.3 
(PhCNCH2), 55.2 (OCH3), 55.3 (OCH3), 72.5 (CPh), 113.9 (2 x CH, PMP), 114.0 (2 x CH, PMP), 
126.1 (2 x CH, Ph), 127.2 (CCH2, PMP), 128.4 (CCH2, PMP), 129.5 (CH, Ph), 129.6 (2 x CH, Ph), 
130.4 (2 x CH, PMP), 130.7 (2 x CH, PMP), 137.8 (C, Ph), 155.0 (PhCNC(O)), 155.6 
(PhCNC(O)C(O)), 159.3 (COCH3, PMP), 159.4 (COCH3, PMP), 168.9 (PhCC(O)), 198.3 (CHO); IR 
(neat) νmax/cm-1 2937w, 1686s, 1514s, 1366w, 1303w, 1248s, 1179m, 1033m; m/z (ES+) 501.2 
([M+H]+, 10%), 1001.4 ([2M+H]+, 100%); HRMS (ES+) 501.2030 [M+H]+, C29H29N2O6 requires 
501.2026. 
6-(2-(1,3-Dioxolan-2-yl)ethyl)-1,4-bis(4-methoxybenzyl)-6-phenylpiperazine-2,3,5-trione 
121 
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Acrolein Michael adduct 120 (10 mg, 0.020 mmol) was added to a solution of p-toluenesulfonic 
acid monohydrate (1 mg, 5 µmol) in 2-ethyl-2-methyl-1,3-dioxolane (100 µL). The reaction 
mixture was stirred at rt for 18 h, diluted with H2O (5 mL) and extracted with CH2Cl2 (3 x 5 mL). 
The combined organic layers were then dried with Na2SO4 and concentrated under reduced 
pressure. Purification by column chromatography (5:2 to 5:3 petrol/EtOAc) afforded acetal 
121 as a white solid (5 mg, 45%). HPLC analysis was used to determine the er (see Table 9 for 
er values) (Daicel Chiralpak OD column, [4:1 hexane/IPA], retention times: 27.0 and 34.3 min). 
Rf 0.29 (1:1 petrol/EtOAc); m.p. 157-159 °C; 1H NMR (300 MHz, CDCl3): δ 1.07-1.23 (2H, m, 
PhCCH2CH2), 2.21-2.35 (1H, m, PhCCHH’), 2.80-2.92 (1H, m, PhCCHH’), 3.64-3.73 (4H, m, 
OCH2CH2O), 3.75 (3H, s, OCH3), 3.76 (3H, s, OCH3), 3.86 (1H, d, J = 14.5 Hz, PhCNCHH’), 4.39 
(1H, t, J = 5.0 Hz, PhCCH2CH2CH), 4.85 (1H, d, J = 14.5 Hz, PhCNCHH’), 4.90 (1H, d, J = 13.5 Hz, 
C(O)NCHH’), 5.03 (1H, d, J = 13.5 Hz, C(O)NCHH’), 6.68-6.79 (4H, m, 4 x CH, PMP), 7.09-7.15 
(2H, m, 2 x CH, PMP), 7.23-7.39 (7H, m, 2 x CH, PMP, 5 x CH, Ph); 13C NMR (100 MHz, CDCl3): 
δ 28.4 (PhCCH2), 30.6 (PhCCH2CH2), 44.1 (C(O)NCH2), 48.1 (PhCNCH2), 55.2 (OCH3), 55.3 
(OCH3), 64.7 (OCH2CH2O), 72.8 (CPh), 103.0 (PhCCH2CH2CH), 113.7 (2 x CH, PMP), 113.8 (2 x 
CH, PMP), 126.4 (2 x CH, Ph), 127.3 (CCH2, PMP), 128.4 (CCH2, PMP), 129.2 (CH, Ph), 129.3 (2 
x CH, Ph), 130.7 (2 x CH, PMP), 130.8 (2 x CH, PMP), 138.4 (C, Ph), 154.7 (PhCNC(O)), 155.9 
(PhCNC(O)C(O)), 159.1 (COCH3, PMP), 159.3 (COCH3, PMP), 169.5 (PhCC(O)); IR (neat) νmax/cm-
1 2955w, 1686s, 1514s, 1367m, 1303m, 1248s, 1179m, 1032m; m/z (ES+) 545.2 ([M+H]+, 
100%); HRMS (ES+) 545.2292 [M+H]+, C31H33N2O7 requires 545.2288. 
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